10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number: 000-53704

WORKHORSE GROUP INC.

(Exact name of registrant as specified in its charter)

Nevada	26-1394771
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

100 Commerce Drive, Loveland, Ohio 45140

(Address of principal executive offices) (Zip Code)

844-937-9547

Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.001 par value per share	WKHS	The NASDAQ Capital Market

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $0.001 par value per share	66,186,447
(Class)	(Outstanding at July 31, 2019)

EXPLANATORY NOTE

As disclosed in Item 4.02(a) of Form 8-K filed with the U.S Securities and Exchange Commission ("SEC") on November 1, 2019, on October 28, 2019, the Audit Committee of the Board of Directors of Workhorse Group, Inc. (the “Company”) concluded, after review and discussion with management, that the Company’s unaudited financial statements as of and for the three and six months ended June 30, 2019 ( the “Financial Statements”) should no longer be relied upon. This Amendment No. 1 to the Company’s Quarterly Report on Form 10-Q (this “Form 10-Q/A”) for the quarterly period ended June 30, 2019, which was filed with the SEC on August 9, 2019 (the “Original Form 10-Q”), restates the Company’s consolidated financial statements as of and for the three and six months ended June 30, 2019, and amends the related Notes and disclosures thereto. The impact on the Company’s financial statements for the three and six months ended June 30, 2019, is to reduce interest expense and the warrant liability for mark-to market adjustments previously recorded, as well as reclassify a portion of the warrant liability to shareholders' equity.

The items amended in the Original Form 10-Q are listed under “Items Amended by this Filing” below.

Condensed consolidated balance sheet:

•Warrant liability;

•Additional paid-in capital; and

•Accumulated deficit

Condensed consolidated statement of operations:

•Interest expense;

•Net loss;

•Net loss attributable to common stockholders; and

•Net loss attributable to common stockholders per share - basic and diluted share

Condensed consolidated statement of shareholders equity:

•Net loss;

•Reclassification of warrant liability

Condensed consolidated statement of cash flows:

•Net loss;

•Change in fair value of warrants

Other than the “Items Amended by this Filing”, disclosures in the Original Form 10-Q remain unchanged. However, for the convenience of the reader, this Form 10-Q/A restates in its entirety, as amended, the Company’s Original Form 10-Q. The Company has not modified or updated disclosures presented in the Original Form 10-Q, except as required to reflect the effects of the restatement. Accordingly, this Form 10-Q/A does not reflect events occurring after the filing of the Original Form 10-Q and no attempt has been made in this Form 10-Q/A to modify or update other disclosures as presented in the Original Form 10-Q, except as specifically referenced herein. Accordingly, this Form 10-Q/A should be read in conjunction with the Company’s filings with the SEC subsequent to the filing of the Original Form 10-Q.

Background of Restatement

The Company identified an accounting misstatement in the historical Financial Statements primarily related to Warrants issued in July 2018 as part of a debt financing (“2018 Warrants”). The 2018 Warrants were originally required to be mark-to-market at each balance sheet date unless a reclassification event occurred which would change the classification of 2018 Warrants to equity instruments. However, based on further analysis, it was determined that on January 1, 2019, the warrants no longer met the criteria to be classified as a liability and should have been reclassified to equity and mark-to-market accounting no longer

applied.

In addition, the Company determined that the classification of certain warrants issued in 2019 to lenders were misclassified as liability financial instruments, while they should have been classified as equity instruments and not marked-to-market.

A summary of the restatement and its effects to the Company’s financial statements for the three and six months ended June 30, 2019 is included within this Form 10-Q/A, is presented in Note 1 in the accompanying Notes to the unaudited condensed consolidated financial statements.

Internal Control Over Financial Reporting

Under the supervision and with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, management conducted a reassessment of the effectiveness of the Company’s disclosure controls and procedures as of June 30, 2019. As a result of that reassessment, management concluded that the Company’s disclosure controls and procedures continued to be ineffective, due to the existence of previously disclosed material weaknesses.

Items Amended by this Filing

The following items included in the Original Form 10-Q are amended by this Form 10-Q/A:

•Part I, Item I – Financial Statements;

•Part I, Item II – Management’s Discussion and Analysis of Financial Condition and Results of Operations

As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by the Company’s principal executive officer and principal financial officer are filed as exhibits 31.1, 31.2, 32.1 and 32.2 to this Form 10-Q/A.

TABLE OF CONTENTS

PART I	FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statements of Stockholders’ Equity (Deficit)	3
	Condensed Consolidated Statements of Cash Flows	5
	Notes to Condensed Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	20
Item 4.	Controls and Procedures	20
PART II	OTHER INFORMATION	22
Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	22
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	23
	SIGNATURES	24

i

Forward-Looking Statements

The discussions in this Quarterly Report contain forward-looking statements reflecting our current expectations that involve risks and uncertainties. When used in this Report, the words “anticipate”, expect”, “plan”, “believe”, “seek”, “estimate” and similar expressions are intended to identify forward-looking statements. These are statements that relate to future periods and include, but are not limited to, statements about the features, benefits and performance of our products, our ability to introduce new product offerings and increase revenue from existing products, expected expenses including those related to selling and marketing, product development and general and administrative, our beliefs regarding the health and growth of the market for our products, anticipated increase in our customer base, expansion of our products functionalities, expected revenue levels and sources of revenue, expected impact, if any, of legal proceedings, the adequacy of liquidity and capital resource, and expected growth in business. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include, but are not limited to, market acceptance for our products, our ability to attract and retain customers for existing and new products, our ability to control our expenses, our ability to recruit and retain employees, legislation and government regulation, shifts in technology, global and local business conditions, our ability to effectively maintain and update our product and service portfolio, the strength of competitive offerings, the prices being charged by those competitors and the risks discussed elsewhere herein. These forward-looking statements speak only as of the date hereof. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

All references in this Form 10-Q that refer to the “Company”, “Workhorse Group”, “Workhorse”, “we,” “us” or “our” are to Workhorse Group Inc. and unless otherwise differentiated, its wholly-owned subsidiaries, Workhorse Technologies Inc., Workhorse Motor Works Inc. and Workhorse Properties Inc.

ii

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Workhorse Group, Inc.

Condensed Consolidated Balance Sheets

June 30, 2019 (Unaudited) and December 31, 2018

	June 30, 2019		December 31, 2018
	As restated
Assets
Current assets:
Cash and cash equivalents	$	23,519,496	$	1,512,750
Lease receivable	42,244		48,271
Inventory	2,197,683		2,533,616
Prepaid expenses and deposits	1,720,319		2,274,595
	27,479,742		6,369,232
Noncurrent assets:
Property, plant and equipment, net of accumulated depreciation of $2,601,263 and $2,407,477 at June 30, 2019 and December 31, 2018	8,009,037		5,237,451
Lease receivable	179,982		198,090
	$	35,668,761	$	11,804,773
Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Accounts payable	$	2,010,333	$	4,340,463
Accrued liabilities	4,047,550		3,946,386
Warranty liability	6,573,560		7,058,769
Warrant liability	15,876,415		1,822,819
Customer deposits	359,000		406,000
Duke financing obligation	1,340,700		1,340,700
Revolving loan	5,854,140		—
	36,061,698		18,915,137
Long-term debt	8,572,182		8,312,079
Mandatory redeemable series B preferred stock	18,409,510		—
Commitments and Contingencies
Stockholders’ equity (deficit):
Series A preferred stock, par value of $.001 per share 75,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2019 and December 31, 2018	—		—
Common stock, par value of $.001 per share 250,000,000 shares authorized, 66,081,812 shares issued and outstanding at June 30, 2019 and 58,270,934 shares issued and outstanding at December 31, 2018	66,082		58,271
Additional paid-in capital	140,527,364		126,076,782
Accumulated deficit	(167,968,075)		(141,557,496)
	(27,374,629)		(15,422,443)
	$	35,668,761	$	11,804,773

See accompanying notes to condensed consolidated financial statements.

1

Workhorse Group, Inc.

Condensed Consolidated Statements of Operations

For the Three and Six Months Ended June 30, 2019 and 2018

(Unaudited)

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
	As restated				As restated
Net sales	$	5,508	$	170,684	$	369,690	$	730,913
Cost of sales	930,164		1,655,905		2,327,770		3,370,275
Gross loss	(924,656)		(1,485,221)		(1,958,080)		(2,639,362)
Operating expenses
Selling, general and administrative	1,996,054		3,003,202		4,086,944		5,403,349
Research and development	1,216,727		1,894,712		2,579,002		4,232,343
Total operating expenses	3,212,781		4,897,914		6,665,946		9,635,692
Interest expense, net	15,922,763		526,162		17,700,346		1,052,049
Net loss	(20,060,200)		(6,909,297)		(26,324,372)		(13,327,103)
Deemed dividends	86,207		765,179		86,207		765,179
Net loss attributable to common stockholders	$	(20,146,407)	$	(7,674,476)	$	(26,410,579)	$	(14,092,282)
Net loss attributable to common stockholders per share - basic and diluted	$	(0.33)	$	(0.18)	$	(0.44)	$	(0.33)
Weighted average number of common shares outstanding	60,530,168		42,406,471		60,530,168		42,406,471

See accompanying notes to condensed consolidated financial statements.

2

Workhorse Group, Inc.

Condensed Consolidated Statements of Stockholders Equity (Deficit)

(Unaudited)

	Common Stock			Series A Preferred Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance, March 31, 2018	41,966,550	$	41,966	—	$	—	$	109,106,507	$	(110,707,807)	$	(1,559,334)
Issuance of common stock	3,034,169	1,065		—	—		2,832,861		—		2,833,926
Stock options and warrants exercised	2,500	3		—	—		2,748		—		2,751
Warrant exchange	—	1,969		—	—		(1,969)		—		—
Deemed dividend, Sept 17 warrants	—	—		—	—		765,179		(765,179)		—
Share based compensation	—	—		—	—		476,085		—		476,085
Net loss	—	—		—	—		—		(6,909,297)		$	(6,909,297)
Balance, June 30, 2018	45,003,219	$	45,003	—	$	—	$	113,181,411	$	(118,382,283)	$	(5,155,869)

	Common Stock			Series A Preferred Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance, December 31, 2017	41,529,181	$	41,529	—	$	—	$	107,760,036	$	(104,290,001)	$	3,511,564
Issuance of common stock	3,429,395	1,460		—	—		4,019,881		—		4,021,341
Stock options and warrants exercised	44,643	45		—	—		90,021		—		90,066
Warrant exchange	—	1,969		—	—		(1,969)		—		—
Deemed dividend, Sept 17 warrants	—	—		—	—		765,179		(765,179)		—
Share based compensation	—	—		—	—		548,263		—		548,263
Net loss	—	—		—	—		—		(13,327,103)		(13,327,103)
Balance, June 30, 2018	45,003,219	$	45,003	—	$	—	$	113,181,411	$	(118,382,283)	$	(5,155,869)

3

Workhorse Group, Inc.

Condensed Consolidated Statements of Stockholders Equity (Deficit) (Continued)

(Unaudited)

As restated

	Common Stock			Series A Preferred Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance,March 31, 2019	61,496,990	$	61,497	—	$	—	$	129,764,361	$	(147,821,668)	$	(17,995,810)
Issuance of common stock	3,957,432	3,958		—	—		2,924,542		—		2,928,500
Stock options and warrants exercised	510,894	511		—	—		(511)		—		—
Deemed dividend	116,496	116					86,091		(86,207)		—
Share based compensation	—	—		—	—		185,848		—		185,848
Effect of reclassification of warrants	—	—		—	—		857,072		—		857,072
Value of warrants issued with preferred stock	—	—		—	—		6,709,961		—		6,709,961
Net loss	—	—		—	—		—		(20,060,200)		(20,060,200)
Balance,June 30, 2019	66,081,812	$	66,082	—	$	—	$	140,527,364	$	(167,968,075)	$	(27,374,629)

	Common Stock			Series A Preferred Stock			Additional Paid-in Capital		Accumulated Deficit		Total Stockholders’ Equity (Deficit)
	Number of Shares	Amount		Number of Shares	Amount
Balance,December 31, 2018	58,270,934	$	58,271	—	$	—	$	126,076,782	$	(141,557,496)	$	(15,422,443)
Issuance of common stock	7,183,488	7,184		—	—		5,921,051		—		5,928,235
Stock options and warrants exercised	510,894	511		—	—		(511)		—		—
Deemed dividend	116,496	116					86,091		(86,207)		—
Share based compensation	—	—		—	—		876,918		—		876,918
Effect of reclassification of warrants	—	—		—	—		857,072		—		857,072
Value of warrants issued with preferred stock	—	—		—	—		6,709,961		—		6,709,961
Net loss	—	—		—	—		—		(26,324,372)		(26,324,372)
Balance,June 30, 2019	66,081,812	$	66,082	—	$	—	$	140,527,364	$	(167,968,075)	$	(27,374,629)

See accompanying notes to the consolidated financial statements.

4

Workhorse Group, Inc.

Condensed Consolidated Statements of Cash Flows

For the Six Months Ended June 30, 2019 and 2018

(Unaudited)

	2019		2018
	As restated
Cash flows from operating activities:
Net loss	$	(26,324,372)	$	(13,327,103)
Adjustments to reconcile net loss to cash used by operations:
Depreciation	193,786		152,525
Amortization of Marathon loan issuance costs	260,103		—
Amortization of discount on Series B preferred stock	119,471		—
Amortized discount and debt issuance costs on Senior Secured Notes	—		987,500
Stock-based compensation	876,918		548,263
Inventory obsolescence reserve	22,221		—
Change in fair value of warrants	14,910,668		—
Effects of changes in operating assets and liabilities:
Accounts receivable and lease receivable	24,135		842,798
Inventory	313,712		(342,727)
Prepaid expenses and deposits	554,276		765,043
Accounts payable and accrued liabilities	(2,228,966)		1,980,433
Warranty	(485,209)		—
Notes payable, related parties	—		550,000
Customer deposits	(47,000)		265,595
Net cash used by operating activities	(11,810,257)		(7,577,673)
Cash flows from investing activities:
Capital expenditures	(2,965,372)		—
Net cash used by investing activities	(2,965,372)		—
Cash flows from financing activities:
Payments on long-term debt	—		(16,770)
Proceeds from revolving loans	5,854,140		—
Proceeds from issuance of series B preferred stock	25,000,000		—
Issuance of common stock	5,928,235		4,021,341
Exercise of warrants and options	—		90,066
Net cash provided by financing activities	36,782,375		4,094,637
Change in cash and cash equivalents	22,006,746		(3,483,036)
Cash and cash equivalents, beginning of the period	1,512,750		4,069,477
Cash and cash equivalents, end of the period	$	23,519,496	$	586,441

See accompanying notes to condensed consolidated financial statements.

5

Workhorse Group Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1.SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES

The following accounting principles and practices are set forth to facilitate the understanding of data presented in the condensed consolidated financial statements:

Nature of operations and principles of consolidation

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us” or “our”) is a technology company focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer, we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Although we operate as a single unit through our subsidiaries, we approach our development through two divisions, Automotive and Aviation. We are currently focused on our core competency of bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of our core focus.

The Company’s wholly owned subsidiaries include Workhorse Technologies Inc., Workhorse Motor Works Inc., Workhorse Properties Inc. and Surefly, Inc

On May 3, 2019, the Company filed an amendment to its Articles of Incorporation to increase its authorized shares of common stock from 100,000,000 to 250,000,000.

Restatement of Previously Issued Consolidated Financial Statements

Subsequent to the filing of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019, filed with the SEC on August 9, 2019, management identified accounting adjustments related to an overstatement of the estimated warrant liability and interest expense. Certain warrants issued to lenders in 2018, were previously classified as liability financial instruments and marked-to-market at each reporting date with a corresponding adjustment to interest expense. On January 1, 2019, due to the payoff of debt to the lenders that the warrants were originally issued to, the warrants no longer met the criteria to be classified as liabilities and should have been reclassified to equity with no future mark-to-market adjustments. The adjustment resulted from the Company not recognizing that a reclassification event had occurred resulting in a change in the classification of certain of the Company’s outstanding warrants.

In addition, the Company determined that the classification of certain warrants issued in 2019 to lenders were misclassified as liability financial instruments, while they should have been classified as equity instruments and not marked-to-market.

Although the reclassification event occurred on January 1, 2019, and the missclassification of the 2019 warrants occurred in early 2019, management has determined that the $300,000 impact to the net loss for the three months ended March 31, 2019 is not material and therefore is not restating that period. The impact of the misstatement for the three months ended March 31, 2019, has been included in the adjustment for the three and six months ended June 30, 2019.

6

The following tables present the effect of the correction discussed above on selected line items of our previously reported consolidated balance sheet, consolidated statement of operations and statement of cash flows as of and for the three and six months ended June 30, 2019.

Condensed Consolidated Balance Sheet
	June 30, 2019
	As originally reported		Adjustments		As restated
Warrant liability	$	33,529,599	$	(17,653,184)	$	15,876,415
Additional paid-in capital	139,670,292		857,072		140,527,364
Accumulated deficit	(184,764,188)		16,796,113		(167,968,075)
Total shareholders' deficit	(45,027,814)		17,653,185		(27,374,629)

Condensed Consolidated Statement of Operations
	Three Months Ended June 30, 2019						Six Months Ended June 30, 2019
	As originally reported		Adjustments		As restated		As originally reported		Adjustments		As restated
Interest expense, net	$	32,718,876	$	(16,796,113)	$	15,922,763	$	34,496,459	$	(16,796,113)	$	17,700,346
Net loss	(36,856,313)		16,796,113		(20,060,200)		(43,120,485)		16,796,113		(26,324,372)
Net loss attributable to common stockholders	(36,942,520)		16,796,113		(20,146,407)		(43,206,692)		16,796,113		(26,410,579)
Net loss attributable to common stockholders per share - basic and diluted	$	(0.61)	$	0.28	$	(0.33)	$	(0.71)	$	0.28	$	(0.44)

Condensed Consolidated Statement of Cash Flows
	Six Months Ended June 30, 2019
	As originally reported	Adjustments	As restated
Net loss	(43,120,485)	16,796,113	(26,324,372)
Change in fair value of warrants	31,706,780	(16,796,112)	14,910,668

Basis of presentation

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has limited revenues and a history of negative working capital and stockholders’ deficits. Our existing capital resources are expected to be sufficient to fund our operations through the end of 2019. Unless and until we are able to generate a sufficient amount of revenue, reduce our costs and/or enter a strategic relationship, we expect to finance future cash needs through public and/or private offerings of equity securities and/or debt financings. If we are not able to obtain additional financing and/or substantially increase revenue from sales, we will be unable to continue as a going concern. These conditions raise substantial doubt about the ability of the Company to continue as a going concern.

In view of these matters, continuation as a going concern is dependent upon the continued operations of the Company, which, in turn, is dependent upon the Company’s ability to meet its financial requirements, raise additional capital,

7

meet its future bank covenant requirements, and successfully carry out its future operations. The financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary, should the Company not continue as a going concern.

The Company has continued to raise capital. Management believes the proceeds from these offerings, future offerings, and the Company’s anticipated revenue, provides an opportunity to continue as a going concern.  If additional funding is required, the Company plans to obtain working capital from either debt or equity financing from the sale of common stock, preferred stock, and/or convertible debentures. Obtaining such working capital is not assured. The Company is currently in a production ramp up mode and placing greater emphasis on manufacturing capability.

The Marathon Credit Facility includes financial covenants that require our compliance beginning in the fourth quarter of 2019. We expect to be able to satisfy the covenant requirements either through results of operations or the available Equity Cure in the Credit Agreement.

In the opinion of Management, the Unaudited Condensed Consolidated Financial Statements include all adjustments that are necessary for the fair presentation of Workhorse’s financial conditions, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. Intercompany balances and transactions are eliminated in consolidation. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto of Workhorse contained in its Annual Report on Form 10-K for the year ended December 31, 2018.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

Certain reclassifications were made to the prior year financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operation or stockholders’ equity (deficit).

2. INVENTORY

As of June 30, 2019, and December 31, 2018, our inventory consisted of the following:

	2019		2018
Raw materials	$	4,285,830	$	4,319,637
Work in process	422,176		702,079
Finished goods	—		—
	4,708,006		5,021,716
Less: Inventory reserve	2,510,323		2,488,100
	$	2,197,683	$	2,533,616

3. REVENUE

Revenue Recognition

Net sales include products and shipping and handling charges, net of estimates for customer allowances. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with the majority of revenue recognized at the point in time the customer obtains control of the products. We recognize revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The majority of our contracts have a single performance obligation and are short term in nature.

Accounts Receivable

8

Credit is extended based upon an evaluation of the customer’s financial condition. Accounts receivable are stated at their estimated net realizable value. The allowance for doubtful accounts is based on an analysis of customer accounts and our historical experience with accounts receivable write-offs. 

The Company has elected the following practical expedient allowed under ASU 2014-09. Performance obligations are satisfied within one year from a given reporting date, consequently we omit disclosure of the transaction price apportioned to remaining performance obligations on open orders

Disaggregation of Revenue

Our revenues related to the following types of business were as follows for the periods ended June 30, 2019:

	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Automotive	—	118,398	240,000	523,252
Aviation	—	—	—	—
Other	5,508	52,286	129,690	207,661
Total revenues	5,508	170,684	369,690	730,913

4. LONG-TERM DEBT (as restated)

Long-term debt consists of the following:

	June 30, 2019		December 31, 2018
Marathon Tranche One Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	$	10,000,000	$	10,000,000
Marathon Tranche Two Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	5,854,140		—
Marathon Credit Agreement unamortized discount and issuance costs	(1,427,818)		(1,687,921)
Net Marathon Credit Agreement	14,426,322		8,312,079
Less current portion	5,854,140		—
Long-term debt	$	8,572,182	$	8,312,079

On December 31, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”), with Marathon Asset Management, LP, on behalf of certain entities it manages, as lenders (collectively, the “Lenders”). The Credit Agreement provided the Company with a $10 million tranche of term loans (the “Tranche One Loan”) which may not be re-borrowed following repayment and (ii) a $25 million tranche of revolving loans which may be re-borrowed following repayment (the “Tranche Two Loans” together with the Tranche One Loan, the “Loans”).

The Trance Two Loan has been classified as current debt, because the agreement includes a lock box and cash sweep feature, which requires current presentation of the debt.

Second Amendment to Credit Agreement

On April 1, 2019, the Company entered into the Second Amendment to the Credit Agreement (the “Marathon Second Amendment”) with the Lenders. The Marathon Second Amendment delayed the application of certain financial covenants including:

(i)the minimum liquidity, providing that at least $4 million must be maintained at all times on or after April 30, 2019 rather than beginning on March 31, 2019;

9

(ii)the maximum total leverage ratio (ratio of total debt borrowed by the Company and its subsidiaries to EBITDA), providing that the maximum total leverage ratio shall not exceed 4.50:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which total leverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement; and

(iii)the maximum debt service coverage ratio (ratio of EBITDA (for the four consecutive fiscal quarters most recently ended, subject to certain adjustments set forth in the Credit Agreement) to interest expense and payments for operating leases), providing that the maximum debt service coverage ratio shall not exceed 1.25:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which debt service coverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement.

Third Amendment to Credit Agreement

On April 30, 2019, the Company entered into the Third Amendment to Credit Agreement (the “Marathon Third Amendment”). The Marathon Third Amendment amended the minimum liquidity covenant, providing that at least $4 million must be maintained at all times at or after May 31, 2019 rather than at all times on or after April 30, 2019. Unless the Company fails to maintain minimum liquidity as of the last day of any calendar month, the Company may cure a failure to maintain minimum liquidity by increasing liquidity to $4.0 million within five business days of the occurrence.

Purchase Warrants

In conjunction with entering into the Credit Agreement, the Company issued each Lender a Common Stock Purchase Warrant to purchase, in the aggregate, 8,053,390 shares of common stock at an exercise price of $1.25 per share exercisable in cash only for a period of three years and then for cash or cashless thereafter (collectively, the “Initial Warrants”). Until the later of the repayment of all obligations owed to the Lenders or two years from the closing date, the Company will be required to issue additional Common Stock Purchase Warrants (the “Additional Warrants”) to the Lenders equal to 10%, in the aggregate, of any additional equity issuances, subject to certain exceptions, on substantially the same terms and conditions of the Initial Warrants, except that (i) the applicable expiration date thereof shall be five years from the issuance date of the applicable warrant, (ii) the initial exercise price shall be a price equal to the price per share of common stock used in the relevant issuance multiplied by 110%, and (iii) the holder shall be entitled to exercise the warrant on a cashless exercise at any time the warrant is exercisable.

On April 16, 2019, the Company entered into an Amendment No. 1 to Common Stock Purchase Warrants with Marathon Asset Management LP, on behalf of certain entities it manages, as warrant holders (collectively, the “Holders”) (collectively, the “Marathon Warrant Amendment”), amending certain terms of the existing warrants issued by the Company in favor of each Holder. Pursuant to the Marathon Warrant Amendment, unless the Company has obtained the approval of its shareholders the number of shares to be issued under warrants held by the Holders shall not exceed 19.99% of the issued and outstanding common stock of the Company as of December 31, 2018. The Marathon Warrant Amendment also provide that the failure to obtain shareholder approval of an increase in the number of authorized shares of common stock of the Company, sufficient to enable the Company to issue common stock upon exercise of the warrants held by each Holder, will constitute an event of default under the existing Credit Agreement.

The Initial Warrants are required to be marked to market at each balance sheet date with a corresponding charge to interest expense. As of June 30, 2019 and December 31, 2018, the warrant liability was $15,876,415 and $965,747, respectively.

The Company has outstanding previously issued warrants to Arosa pursuant to agreements for debt issued in 2018. The Arosa debt was subsequently paid off on December 31, 2018, with the proceeds from the Credit Agreement. Through and including December 31, 2018, the warrants held by Arosa were required to be marked-to-market as the warrants were classified as liabilities. On January 1, 2019, the warrants no longer included dilution protection and therefore no longer met the criteria for liability classification and were reclassified to equity. As a result of the reclassification event, the $857,072 warrant liability for the Arosa warrants was reclassified as an increase to additional paid-in capital in 2019.

5. DUKE FINANCING OBLIGATION

On November 28, 2018, the Company entered into a Sales Agreement with Duke Energy One, Inc (“Duke”) pursuant to which the Company sold Duke 615,000 battery cells (the “615,000 Cells”) in consideration of $1,340,700. The

10

Company will continue to use the cells in the near term for the delivery of trucks to UPS and DHL. Until October 15, 2019, the Company has the right and option to require Duke to sell the 615,000 Cells back to the Company and Duke has the right and option to require the Company to purchase the 615,000 Cells at price equal to the price the 615,000 Cells were sold.

On November 28, 2018, in consideration for consenting to the Company selling the 615,000 Cells to Duke, which served as collateral for Arosa for their Loan Agreement, the Company entered into a Limited Consent, Waiver and Release pursuant to which the Company issued Arosa 2,000,000 shares of common stock and restruck the exercise price of warrants previously issued to $1.25 per share.

The Duke transactions was accounted for as a financing obligation and as such, the Company has recorded a $1,340,700 liability related to the transaction.

6. MANDATORY REDEEMABLE SERIES B PREFERRED STOCK

Commencing May 31, 2019 through June 5, 2019 (“Closing Date”), the Company entered into Subscription Agreements with institutional investors pursuant to which the investors purchased 1,250,000 units consisting of one share of Series B Preferred Stock (the “Preferred Stock”), with a stated value of $20.00 per share (the “Stated Value”) and a common stock purchase warrant to purchase 7.41 shares of the common stock (the “Warrants”) for an aggregate of purchase price of $25.0 million.

The Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights upon liquidation, winding-up or dissolution. The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% per annum on the Stated Value of the Preferred Stock. Accrued dividends will be payable quarterly in shares of common stock of the Company based on a fixed share price of $1.62. The Warrants have an exercise price of $1.62 per share, which was in excess of the closing price of $1.60 on May 30, 2019, and are immediately exercisable and will expire seven years from the date of issuance.

The Preferred Stock is not convertible and does not hold voting rights.

On the fourth anniversary of the Closing Date, the Company is required to redeem all the outstanding shares of the Preferred Stock at the Stated Value, plus accrued and unpaid dividends. At any time prior to such date, the Company subject to the repayment and retirement of the Credit Agreement, may redeem any outstanding shares of Preferred Stock at the Stated Value, plus accrued and unpaid dividends (“Optional Redemption”). Notwithstanding the foregoing, the Company may elect an Optional Redemption prior to the fourth anniversary of the Closing Date so long as it obtains from the lenders to the Credit Agreement their prior written consent to such Optional Redemption.

The aggregate number of shares of common stock issued in payment of dividends on the Preferred Stock when added to the number of shares of common stock issued upon exercise of any warrants shall not exceed 19.9% of either (a) the total number of shares of common stock outstanding on the date hereof or (b) the total voting power of the Company’s securities outstanding on the date hereof that are entitled to vote on a matter being voted on by holders of the common stock, unless and until the Company obtains stockholder approval permitting such issuances.

As the Preferred Stock is mandatorily redeemable, it is presented as a liability on the condensed consolidated balance sheet. All dividends payable on the Preferred Stock are classified as interest expense.

The Preferred Stock and Warrants have been determined to be freestanding financial instruments and have been accounted for separately. The Warrants are considered equity instruments and are not required to be recorded as a liability and marked-to-market at each reporting period. On the date of issuance, the value of the Warrants was determined to be $6.7 million, which was determined using the Black-Scholes valuation model. The fair value of the warrants was recorded as an increase to Additional Paid-In Capital and a discount of the Preferred Stock. The discount will be amortized to interest expense through May 2023.

7. 

11

STOCK-BASED COMPENSATION

Options to directors, officers, consultants and employees

The Company maintains, as adopted by the board of directors, the 2019 Stock Incentive Plan as well as previous years plans (the “Plans”) providing for the issuance of equity based awards to employees, officers, directors or consultants of the Company. Non-qualified stock options granted under the plans may only be granted with an exercise price equal to the fair market value of the Company’s common stock on the date of grant.  Awards under the plans may be either vested or unvested options.

In addition to the Plans, the Company has granted, on various dates, stock options to directors, officers, consultants and employees to purchase common stock of the Company. The terms, exercise prices and vesting of these awards vary.

The following table summarizes option activity for directors, officers, consultants and employees:

		Outstanding Stock Options
	Options Available for Grant	Number of Options Outstanding	Weighted Average Exercise Price per Option		Weighted Average Grant Date Fair Value  per Option		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2017	4,145,774	3,851,371	$	3.11	$	1.84	43
Granted	(340,000)	340,000	1.18		0.54		56
Exercised	—	(52,500)	1.24		0.68		—
Forfeited	—	—	—		—		—
Expired	—	(271,250)	3.22		1.58		—
Balance, December 31, 2018	3,805,774	3,867,621	4.05		$	1.84	64
Additional Shares Authorized under 2019 Plan	8,000,000	—
Granted	(2,400,000)	2,400,000	0.96		0.53		81
Exercised	—	(498,552)	0.13		1.92
Forfeited	1,375,069	(1,375,069)	4.75		1.95		27
Expired	—	—
Balance, June 30, 2019	10,780,843	4,394,000	$	2.60	$	1.32	94

8. INCOME TAXES

As the Company has not generated taxable income since inception, the cumulative deferred tax assets remain fully reserved, and no provision or liability for federal or state income taxes has been included in the financial statements.

9. EARNINGS PER SHARE

Basic loss per share is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. For all periods presented, due to the Company’s net losses, all of the Company’s common stock equivalents were excluded from the calculation of diluted loss per share because they were anti-dilutive.

12

10. RECENT ACCOUNTING DEVELOPMENTS

Accounting Guidance Adopted in 2019

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which requires a lessee to recognize in the statement of financial position a liability to make lease payments (“the lease liability”) and a right-of-use asset representing its right to use the underlying asset for the lease term, initially measured at the present value of the lease payments. A lessee shall classify a lease as a finance lease or an operating lease.

Amortization of the right-of-use asset shall be on a straight-line basis, unless another basis is more representative of the pattern in which the lessee expects to consume the right-of-use asset’s future economic benefits. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The amendments in this update were applied using the current period adjustment method, as defined, and were effective on January 1, 2019. The adoption of this standard did not have a material impact on the condensed consolidated financial statements.

11. SHARE HOLDERS EQUITY (DEFICIT)

Stock Offerings

On June 4, 2018, the Company and holders of all outstanding Warrants to Purchase Common Stock of the Company issued on September 18, 2017 (collectively, the “Warrants”) entered into separate, privately-negotiated exchange agreements (the “Exchange Agreements”), pursuant to which the Company issued an aggregate of 1,968,736 shares of the Company’s common stock in exchange for the Warrants. In addition, the “Down Round” feature of the Warrants was triggered in the second quarter of 2018, causing the strike price to decrease from $3.80 per share to $2.62 per share. As a result, the Company recorded a deemed dividend of $765,179 which represents the fair value transferred to the Warrant holders from the Down Round being triggered. The deemed dividend was recorded as a reduction of Retained Earnings and increase in Additional Paid-in-Capital and reduced net income available to common shareholders by the same amount.

Commencing February 11, 2019, the Company entered into and closed Subscription Agreements with accredited investors (the “February 2019 Accredited Investors”) for the purchase of 1,613,683 shares of the Company’s common stock for a purchase price of $1,465,056. If, prior to the six month anniversary, the Company issues shares of its common stock for a purchase price per share less than the purchase price paid by the February 2019 Accredited Investors (a “Down Round”), the Company will issue additional shares of common stock (for no additional consideration) such that the effective purchase price per share is equal to the purchase price per share paid in the Down Round. The Down Round provisions were triggered by the May 1, 2019 sale of common stock and an additional 116,496 shares of common stock were issued to the February 2019 Accredited Investors. The issuance of the additional shares is accounted for as a $86,207 deemed dividend.

Benjamin Samuels and Gerald Budde, directors of the Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of this offering at a per share purchase was $0.9501, which was above the closing price the date prior to close. They did not receive the Down Round protection.

On May 1, 2019, the Company closed under a registered public offering the sale of $3,957,432 shares of Common Stock for a purchase price of $0.74 per share. The net proceeds to the Company were approximately $2.9 million, after deducting estimated expenses payable by the Company. The Company expects to use the net proceeds from this offering for working capital, general corporate purposes and repayment of debt and other obligations.

13

Warrants

In connection with the issuance of debt and preferred stock, the Company has issued warrants to purchase share of Common Stock.

The following table summarizes warrant activity for the period:

	Number of Warrants	Weighted Average Exercise Price per Warrant		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2018	17,818,844	$	1.84	52
Granted, Series B Preferred Stock	9,262,500	1.62		48
Granted, Marathon debt	1,840,275	1.40		60
Exercised	—
Balance, June 30, 2019	28,921,619	$	2.58	69

12. SUBSEQUENT EVENTS

The Company evaluates events and transactions occurring subsequent to the date of the condensed consolidated financial statements for matters requiring recognition or disclosure in the condensed consolidated financial statements. The accompanying condensed consolidated financial statements consider events through the date on which the condensed consolidated financial statements were available to be issued.

14

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

As discussed in detail in footnote 1 to the condensed consolidated financial statements, the Company has restated its financial statements as of and for the three and six months ended June 30, 2019, and the following information reflects the impact of that restatement.

Overview and Quarter Highlights

We are a technology company focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer, we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Although we operate as a single unit through our subsidiaries, we approach our development through two divisions, Automotive and Aviation. We are currently focused on our core competency of bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of our core focus.

Workhorse electric delivery vans are currently in production and are in use by our customers on U.S. roads. Our delivery customers include companies such as UPS, FedEx Express, Alpha Baking and W.B. Mason. Data from our in-house developed telematics system demonstrates our vehicles on the road are averaging approximately a 500% increase in fuel economy as compared to conventional gasoline-based trucks of the same size and duty cycle.

In addition to improved fuel economy, we anticipate that the performance of our vehicles on-route will reduce long-term vehicle maintenance expense by approximately 50% as compared to fossil-fueled trucks.

We are an OEM capable of manufacturing Class 3-6 commercial-grade, medium-duty truck chassis at our Union City, Indiana facility, marketed under the Workhorse® brand. All Workhorse last mile delivery vans are assembled in the Union City assembly facility.

From our development modeling and the existing performance of our electric vehicles on American roads, we estimate that our E-GEN Range-Extended Electric delivery vans will save over $150,000 in fuel and maintenance savings over the 20-year life of the vehicle. Due to the positive return-on-investment, we place a premium price for our vehicles when selling to major fleet buyers. We expect that fleet buyers will be able to achieve a four-year or better return-on-investment (without government incentives), which we believe justifies the higher acquisition cost of our vehicles.

Our goal is to continue to increase sales and production, while executing on our cost-down strategy to a point that will enable us to achieve gross margin profitability of the last mile-delivery van platform. As a key strategy, we have developed the Workhorse N-GEN platform, which has been accelerated from our development efforts on the USPS Next Generation Delivery Vehicle (“NGDV”) program.

The Workhorse N-GEN electric cargo van platform will be available in multiple size configurations, 450, 700 and 1,000 cubic feet. We intend to initiate the launch with the 450 cubic foot configuration where it is designed to compete with the Sprinter, Transit and RAM ProMaster gasoline/diesel trucks in the commercial sector with an emphasis on last-mile delivery and other service-oriented businesses, such as telecom. This ultra-low floor platform incorporates state-of-the-art safety features, economy and performance. We expect these vehicles offer fleet operators the most favorable total cost-of-ownership of any comparable vehicle available today. We believe we are the first American OEM to market a U.S. built electric cargo van, and early indications of fleet interest are significant. We expect the N-GEN trucks will be supported by our Ryder Systems partnership. Using N-GEN light duty prototypes, we delivered over 100,000 packages in San Francisco and Ohio during our testing. During the period we achieved 50 MPGe and successfully demonstrated the role the vehicle can have in last mile delivery.

As a direct result of the USPS award and development efforts, Workhorse has begun development on the Workhorse W-15, a medium- and light-duty pickup truck platform aimed at commercial fleets. The W-15 pickup truck powertrain is a smaller version of its sister vehicle, the medium-duty battery electric powertrain. Workhorse is currently evaluating licensing opportunities with respect to its W-15 light duty pickup truck platform.

15

Our HorseFly™ delivery drone is a custom designed, purpose-built drone that is fully integrated in our electric trucks. HorseFly is an octocopter designed with a maximum gross weight of 30 lbs., a 10 lb. payload and a maximum air speed of 50 mph. It is designed and built to be rugged and consisting of redundant systems to further meet the FAA’s required rules and regulations.

SureFly™ is our entry into the emerging VTOL market. It is designed to be a two-person, 400-pound payload aircraft with a hybrid internal combustion/electric power generation system. Our approach in the design is to build the safest and simplest way to fly rotary wing aircraft in the world. We believe it is a practical answer to personal flight, as well as, commercial transportation segments, including air taxi series, agriculture and beyond.

The FAA to-date has granted 14 separate Experimental Airworthiness Certifications, registered as N834LW, for the aircraft. These certifications come after an extensive design review and inspection of the aircraft with each renewed certificate.

In November 2018, Workhorse signed cooperative research and development agreement with a branch of the U.S. Military to test SureFly with a specific focus on military applications. This further expands the potential market for the aircraft.

We are continuing with our efforts to consummate a sale of the SureFly business although we cannot guarantee that we will be successful in such efforts. We are currently in ongoing negotiations and due diligence procedures with a potential buyer. There are no assurances that these activities will result in the ultimate sale of the business.

Results of Operations

Our condensed consolidated statement of operations data for the period presented follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
	As restated				As restated
Net sales	$	5,508	$	170,684	$	369,690	$	730,913
Cost of sales	930,164		1,655,905		2,327,770		3,370,275
Gross loss	(924,656)		(1,485,221)		(1,958,080)		(2,639,362)
Operating expenses:
Selling, general and administrative	1,996,054		3,003,202		4,086,944		5,403,349
Research and development	1,216,727		1,894,712		2,579,002		4,232,343
Total operating expenses	3,212,781		4,897,914		6,665,946		9,635,692
Interest expense, net	15,922,763		526,162		17,700,346		1,052,049
Net loss	$	(20,060,200)	$	(6,909,297)	$	(26,324,372)	$	(13,327,103)

Sales

Net sales for the three months ended June 30, 2019 and 2018 were approximately $6,000 and $0.2 million, respectively. The decrease was primarily due to a decrease in volume of trucks sold.

Net sales for the six months ended June 30, 2019 and 2018 were approximately $0.4 million and $0.7 million, respectively. The decrease was primarily due to a decrease in volume of trucks sold partially offset by improved pricing in 2019.

Cost of Sales

Cost of sales for the three months ended June 30, 2019 and 2018 were $0.9 million and $1.7 million, respectively. The cost of sales decrease was primarily due to the decrease in volume of trucks sold due to strategic shift to the development of the N-GEN platform. Cost of sales included a $0.8 million charge for excess and obsolete inventory for the period ended June 30, 2019.

16

Cost of sales for the six months ended June 30, 2019 and 2018 were $2.3 million and $3.4 million, respectively. The cost of sales decrease was primarily due to a decrease in volume of trucks sold due to strategic shift to the development of the N-GEN platform.

17

Selling, General and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses during the three months ended June 30, 2019 and 2018 were $2.0 million and $3.0 million, respectively. The decrease is primarily due to lower spending for marketing and employee-related costs.

SG&A expenses during the six months ended June 30, 2019 and 2018 were $4.1 million and $5.4 million, respectively. The decrease related primarily to lower spending in areas such as marketing and employee-related costs partially offset by an increase in stock compensation expense of approximately $0.4 million.

Research and Development Expenses

Research and development (“R&D”) expenses during the three months ended June 30, 2019 and 2018 were $1.2 million and $1.9 million, respectively. The decrease in R&D expenses is due to the decrease in product design and employee related costs for the USPS NGDV and SureFly.

R&D expenses during the six months ended June 30, 2019 and 2018 were $2.6 million and $4.2 million, respectively. The decrease in R&D expenses is due to the decrease in prototype and product design expenses for the USPS NGDV and SureFly.

Interest Expense, Net

Interest expense, net for the three months ended June 30, 2019 and 2018 was $15.9 million and $0.5 million, respectively. The increase was primarily attributable a $14.6 million mark-to-market adjustment of warrants issued to lenders in connection with our financings as well as the higher levels of debt. 

Interest expense, net for the six months ended June 30, 2019 and 2018 was $17.7 million and $1.1 million, respectively. The increase was primarily attributable the impact of a $14.9 million mark-to-market adjustment of warrants issued to lenders in connection with our financings as well as the higher levels of debt.

Liquidity and Capital Resources

Cash Requirements

From inception, we have financed our operations primarily through sales of equity securities and borrowings. We have consumed substantial amounts of capital to date as we continue our R&D activities and manufacturing our vehicles.

As of June 30, 2019, we had approximately $23.5 million in cash and cash equivalents, as compared to approximately $1.5 million as of December 31, 2018, an increase of $22.0 million. The increase was primarily attributable to the $25.0 million sale of Series B Preferred stock, the amount drawn on the Marathon Tranche Two debt and sales of our common stock. These cash inflows were partially offset by the operating loss for the period.

The Marathon Credit Facility includes financial covenants that require our compliance beginning in the fourth quarter of 2019. We expect to be able to satisfy the covenant requirements either through results of operations or the available Equity Cure in the Credit Agreement.

We believe our existing capital resources ($23.5 million of cash at June 30, 2019) and our Marathon revolving credit loans will be sufficient to support our current and projected funding requirements through the end of 2019. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we currently expect. Because of the numerous risks and uncertainties associated with the development of our business and research and development activities, including risks and uncertainties that could impact the rate of progress of our development activities, we are unable to estimate with certainty the amounts of increased capital outlays and operating expenditures.

Our operations will require additional funding for the foreseeable future. Unless and until we are able to generate a sufficient amount of revenue and reduce our costs, we expect to finance future cash needs through public and/or private offerings of equity securities, debt financings and/or monetization of existing assets. With the exception of contingent and royalty payments that we may receive under our existing collaborations, we do not currently have any committed future funding. To the extent we raise additional capital by issuing equity securities, our stockholders could at that time experience substantial dilution. Any debt financing we are able to obtain may involve operating covenants that restrict our business.

18

Our future funding requirements will depend upon many factors, including, but not limited to:

•our ability to acquire or license other technologies or compounds we may seek to pursue;

•our ability to manage our growth;

•competing technological and market developments;

•the costs and timing of obtaining, enforcing and defending our patent and other intellectual property rights; and

•expenses associated with any unforeseen litigation.

Insufficient funds have required and may continue to cause us to delay, scale back or eliminate some or all of our research or development programs, limit our sales activities, limit or cease production or negatively impact our operations.

For the six months ended June 30, 2019, we maintained an investment portfolio primarily in money market funds. Cash in excess of immediate requirements is invested with regard to liquidity and capital preservation. Wherever possible, we seek to minimize the potential effects of concentration and degrees of risk. We will continue to monitor the impact of the changes in the conditions of the credit and financial markets to our investment portfolio and assess if future changes in our investment strategy are necessary

Summary of Cash Flows

	Six Months Ended June 30,
	2019		2018
Net cash used by operating activities	$	(11,810,257)	$	(7,577,673)
Net cash used by investing activities	$	(2,965,372)	$	—
Net cash provided by financing activities	$	36,782,375	$	4,094,637

Cash Flows from Operating Activities

Our cash flows from operating activities are affected by our cash investments to support the business in research and development, manufacturing, selling, general and administration and interest expense. Our operating cash flows are also affected by our working capital needs to support fluctuations in inventory, personnel expenses, accounts payable and other current assets and liabilities.

During the six months ended June 30, 2019 and 2018, cash used by operating activities was $11.8 million and $7.6 million, respectively. The increase in net cash used in operations in 2019 as compared to 2018 was mainly due to changes in accounts receivable, accounts payable and accrued liabilities.

Cash Flows from Investing Activities

During the six months ended June 30, 2019 and 2018, net cash used in investing activities was $3.0 million and zero, respectively. The increase in cash flows used in investing activities was primarily driven by investing in tooling for new products.

Cash Flows from Financing Activities

During the six months ended June 30, 2019 and 2018, net cash provided by financing activities was $36.8 million and $4.1 million, respectively. The increase in cash flows from financing activities was primarily driven by the $25.0 million of proceeds from the sale of Series B Preferred Stock, the $5.8 million drawn on the Marathon Tranche Two debt and $5.9 million of proceeds received from the sale of common stock.

The Company may seek to raise additional capital through public or private debt or equity financings in order to fund its operations.

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

19

Critical Accounting Policies

Our accounting policies are fundamental to understanding management’s discussion and analysis of financial condition and results of operations. Our Unaudited Condensed Consolidated Financial Statements are prepared in conformity with GAAP and follow general practices within the industry in which we operate. The preparation of the financial statements requires management to make certain judgments and assumptions in determining accounting estimates. Accounting estimates are considered critical if the estimate requires management to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and different estimates reasonably could have been used in the current period, or changes in the accounting estimate are reasonably likely to occur from period to period, that would have a material impact on the presentation of our financial condition, changes in financial condition or results of operations.

For a discussion of our critical accounting policies and estimates, see “Critical Accounting Policies” included in our Annual Report on Form 10-K for the year ended December 31, 2018, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” We have made no significant changes to our critical accounting policies and estimates from those described in our Annual Report on Form 10-K for the year ended December 31, 2018, except as follows:

Warrant Liability

We account for certain common stock warrants that are outstanding as a liability at fair value which is marked to market at the end of each reporting period. The liability is subject to remeasurement at each balance sheet date until the warrants are exercised or expire and any change in fair value is recognized as an adjustment to current period interest expense. The fair value of the warrants is measured using a Black Scholes model which includes various inputs, including the market price of our common stock on the balance sheet date and estimated volatility of our common stock. Any significant change in the market price of our common stock may significantly change the value of the liability and impact our results of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For a discussion of our quantitative and qualitative disclosures about market risk, see “Quantitative and Qualitative Disclosures About Market Risks” included in our Annual Report on Form 10-K for the year ended December 31, 2018, under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” There have been no material changes to the information provided in our Annual Report on Form 10-K for the year ended December 31, 2018.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Pursuant to Rules 13a-15(b) and 15-d-15(b) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer of the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this report. The term “disclosure controls and procedures”, as defined under Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting that existed as of June 30, 2019, as discussed below.

As previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018, we identified the following material weaknesses:

•The Company has not established adequate financial reporting monitoring activities to mitigate the risk of accounting errors

20

•The lack of a fully implemented enterprise resource planning (“ERP”) system caused over reliance on manual entries.

With respect to our internal control over financial reporting, these material weaknesses have been and continue to be discussed among management and our Audit Committee. Management intends to review, revise and improve our internal control over financial reporting until the material weaknesses in internal control over financial reporting are remediated.

Management’s specific remediation to address these material weaknesses will and has included among other items:

•Complete implementation of the ERP system modules covering purchase orders and inventory.

•Hire an international accounting firm to assist the company with a broad-based review of our internal control environment including the identification of controls gaps and implementation of controls to remediate those gaps.

We believe the initiated remediation measures will strengthen our internal control over financial reporting and should eventually remediate the material weaknesses identified. However, because we are still assessing the design and operating effectiveness of these measures and need to put more controls in place, the identified material weaknesses have not been remediated as of June 30, 2019. We will continue to monitor the effectiveness of these remediation measures and will make any changes and take such other actions that we deem appropriate.

We assessed the material weaknesses’ impact to the condensed consolidated financial statements to ensure they were prepared in accordance with GAAP and present fairly the condensed consolidated financial position, financial results of operations and cash flows as of and for the three months ended June 30, 2019. Based on these additional procedures and assessment, we concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material aspects, our financial position, results of operations and cash flows for the periods presented.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

21

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved from time to time in legal proceedings incidental to the conduct of our business. We do not believe that any liability that may result from these proceedings will have a material adverse effect on our Unaudited Condensed Consolidated Financial Statements. On July 18, 2019, All Cell Technologies, LLC and Illinois Institute of Technology filed a Complaint for Patent Infringement against the Company in the United States District Court for the Southern District of Indiana.  Management of the Company believes this lawsuit is baseless and intends to defend itself vigorously.

ITEM 1A. RISK FACTORS

For a detailed discussion of risk factors affecting us, see “Part I – Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

February 2019 Private Placement

Commencing February 11, 2019, the Company entered into and closed Subscription Agreements with accredited investors (the “February 2019 Accredited Investors”) pursuant to which the February 2019 Accredited Investors purchased 1,616,683 shares of the Company’s common stock for a purchase price of $1,465,056. If, prior to the six month anniversary, the Company issues shares of its common stock for a purchase price per share less than the purchase price paid by the February 2019 Accredited Investors subject to standard carve-outs (a “Down Round”), the Company will issue additional shares of common stock (for no additional consideration) to the February 2019 Accredited Investors such that the effective purchase price per share is equal to the purchase price per share paid in the Down Round. Benjamin Samuels and Gerald Budde, directors of the Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of this offering at a per share purchase was $0.9501, which was above the closing price the date prior to close. They did not receive the Down Round protection.

Series B Preferred Stock Placement

Commencing May 31, 2019 through June 5, 2019, the Company entered into Subscription Agreements with institutional investors pursuant to which the investors for an aggregate purchase price of $25,000,000 purchased 1,250,000 units consisting of (i) one newly-issued share of Series B Preferred Stock, with a stated value of $20.00 per share (the “Stated Value”) and a par value of $0.001 per share (the “Preferred Stock”), and (ii) a common stock purchase warrant to purchase 7.41 shares of the common stock, par value $0.001 per share, of the Company. (the “Warrants”). The closing with respect to approximately $15,000,000 occurred on May 31, 2019 and the balance of approximately $10,000,000 will close on June 10, 2019.

The rights, preferences, privileges and limitations of the Preferred Stock are set forth in a certificate of designation filed by the Company with the Secretary of State of the State of Nevada (the “Certificate of Designation”). The Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights upon liquidation, winding-up or dissolution. The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% simple interest per annum on the Stated Value of the Preferred Stock. Accrued dividends will be payable quarterly in shares of common stock of the Company based on a share price of $1.62, which was the average closing price of the Company’s common stock on the five trading days immediately preceding May 31, 2019 and in excess of the closing price of $1.60 on May 30, 2019.

The Preferred Stock is not convertible and does not hold voting rights. Upon any liquidation, dissolution or winding up of the Company, liquidation of the Company’s assets will be made in the following order of priority: (a) first, payment or provision for payment of debts and other liabilities; (b) second, payment to the holders of the Preferred Stock an amount with respect to each share of the Preferred Stock’s Stated Value plus any accrued but unpaid dividends thereon; and (c) third, payment to the holders of common stock.

On the fourth anniversary of the Closing Date, the Company shall redeem all the outstanding shares of the Preferred Stock at the Stated Value, plus accrued and unpaid dividends. At any time prior to such date, the Company subject to the repayment and retirement, in accordance with its terms, of the Credit Agreement dated as of December 31, 2018 (the “Credit Agreement”), among the Company, as the borrower, the lenders thereto and Wilmington Trust, National Association, as Agent, the Company may, in its sole discretion, redeem any outstanding shares of Preferred Stock at the Stated Value, plus accrued and unpaid dividends (“Optional Redemption”). Notwithstanding the foregoing, the Company may effect an Optional Redemption prior to

22

the fourth anniversary of the Closing Date so long as it obtains from the lenders to the Credit Agreement their prior written consent to such Optional Redemption.

The Warrants have an exercise price of $1.62 per share, which was in excess of the closing price of $1.60 on May 30, 2019, are immediately exercisable and will expire seven years from the date of issuance.

Notwithstanding anything herein to the contrary, the aggregate number of shares of common stock issued in payment of dividends on the Preferred Stock when added to the number of shares of common stock issued upon exercise of any warrants shall not exceed 19.9% of either (a) the total number of shares of common stock outstanding on the date hereof or (b) the total voting power of the Company’s securities outstanding on the date hereof that are entitled to vote on a matter being voted on by holders of the common stock, unless and until the Company obtains stockholder approval permitting such issuances in accordance with applicable rules of the NASDAQ Capital Market.

The offer, sale and issuance of the above securities was made to accredited investors and the Company relied upon the exemptions contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated thereunder with regard to the sale. No advertising or general solicitation was employed in offering the securities. The offer and sales were made to accredited investors and transfer of the common stock will be restricted by the Company in accordance with the requirements of the Securities Act of 1933, as amended.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None

ITEM 6. EXHIBITS

Exhibit No.	Description
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
EX-101.INS	XBRL INSTANCE DOCUMENT
EX-101.SCH	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB	XBRL TAXONOMY EXTENSION LABELS LINKBASE
EX-101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

* Filed herewith.

23

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	WORKHORSE GROUP INC.
Dated: November 1, 2019	By:	/s/ Duane A. Hughes
		Name: Duane A. Hughes Title:   Chief Executive Officer (Principal Executive Officer)

Dated: November 1, 2019	By:	/s/ Paul Gaitan
		Name: Paul Gaitan Title:   Chief Financial Officer (Principal Financial and Accounting Officer)

24

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Duane A. Hughes, Chief Executive Officer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Workhorse Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial data information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: November 1, 2019	/s/Duane A. Hughes
	Duane A. Hughes, Chief Executive Officer (Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Paul Gaitan, Chief Financial Officer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Workhorse Group Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial data information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.

Date: November 1, 2019	/s/ Paul Gaitan
	Paul Gaitan, Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly report of Workhorse Group Inc. (the "Company") on Form 10-Q for the period ended June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Duane A. Hughes, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2019	/s/Duane A. Hughes
	Duane A. Hughes, Chief Executive Officer (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly report of Workhorse Group Inc. (the "Company") on Form 10-Q for the period ended June 30, 2019 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Paul Gaitan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 1, 2019	/s/ Paul Gaitan
	Paul Gaitan, Chief Executive Officer (Principal Executive Officer)

XML

Summary of Significant Accounting Principles - Adjustment (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2018	Dec. 31, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liability	$ 15,876,415		$ 15,876,415			$ 1,822,819
Additional paid-in capital	140,527,364		140,527,364			126,076,782
Accumulated deficit	(167,968,075)		(167,968,075)			(141,557,496)
Total shareholders' deficit	(27,374,629)	$ (5,155,869)	(27,374,629)	$ (5,155,869)	$ (17,995,810)	$ (15,422,443)	$ (1,559,334)	$ 3,511,564
Interest expense, net	15,922,763	526,162	17,700,346	1,052,049
Net loss	(20,060,200)	(6,909,297)	(26,324,372)	(13,327,103)
Net loss attributable to common stockholders	$ (20,146,407)	$ (7,674,476)	$ (26,410,579)	$ (14,092,282)
Basic and diluted earnings per share (in usd per share)	$ (0.33)	$ (0.18)	$ (0.44)	$ (0.33)
Change in fair value of warrants			$ 14,910,668	$ 0
Previously Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liability	$ 33,529,599		33,529,599
Additional paid-in capital	139,670,292		139,670,292
Accumulated deficit	(184,764,188)		(184,764,188)
Total shareholders' deficit	(45,027,814)		(45,027,814)
Interest expense, net	32,718,876		34,496,459
Net loss	(36,856,313)		(43,120,485)
Net loss attributable to common stockholders	$ (36,942,520)		$ (43,206,692)
Basic and diluted earnings per share (in usd per share)	$ (0.61)		$ (0.71)
Change in fair value of warrants			$ 31,706,780
Restatement Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Warrant liability	$ (17,653,184)		(17,653,184)
Additional paid-in capital	857,072		857,072
Accumulated deficit	16,796,113		16,796,113
Total shareholders' deficit	17,653,185		17,653,185
Interest expense, net	(16,796,113)		(16,796,113)
Net loss	16,796,113		16,796,113
Net loss attributable to common stockholders	$ 16,796,113		$ 16,796,113
Basic and diluted earnings per share (in usd per share)	$ 0.28		$ 0.28
Change in fair value of warrants			$ (16,796,112)

XML

Long-Term Debt (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments [Table Text Block]

Long-term debt consists of the following:

	June 30, 2019		December 31, 2018
Marathon Tranche One Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	$	10,000,000	$	10,000,000
Marathon Tranche Two Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	5,854,140		—
Marathon Credit Agreement unamortized discount and issuance costs	(1,427,818)		(1,687,921)
Net Marathon Credit Agreement	14,426,322		8,312,079
Less current portion	5,854,140		—
Long-term debt	$	8,572,182	$	8,312,079

XML

Summary of Significant Accounting Principles (Policies)

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of operations and principles of consolidation

Nature of operations and principles of consolidation

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us” or “our”) is a technology company focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer, we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Although we operate as a single unit through our subsidiaries, we approach our development through two divisions, Automotive and Aviation. We are currently focused on our core competency of bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of our core focus.

The Company’s wholly owned subsidiaries include Workhorse Technologies Inc., Workhorse Motor Works Inc., Workhorse Properties Inc. and Surefly, Inc

On May 3, 2019, the Company filed an amendment to its Articles of Incorporation to increase its authorized shares of common stock from 100,000,000 to 250,000,000.

Basis of Accounting, Policy [Policy Text Block]

Basis of presentation

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has limited revenues and a history of negative working capital and stockholders’ deficits. Our existing capital resources are expected to be sufficient to fund our operations through the end of 2019. Unless and until we are able to generate a sufficient amount of revenue, reduce our costs and/or enter a strategic relationship, we expect to finance future cash needs through public and/or private offerings of equity securities and/or debt financings. If we are not able to obtain additional financing and/or substantially increase revenue from sales, we will be unable to continue as a going concern. These conditions raise substantial doubt about the ability of the Company to continue as a going concern.

In view of these matters, continuation as a going concern is dependent upon the continued operations of the Company, which, in turn, is dependent upon the Company’s ability to meet its financial requirements, raise additional capital,

meet its future bank covenant requirements, and successfully carry out its future operations. The financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary, should the Company not continue as a going concern.

The Company has continued to raise capital. Management believes the proceeds from these offerings, future offerings, and the Company’s anticipated revenue, provides an opportunity to continue as a going concern.  If additional funding is required, the Company plans to obtain working capital from either debt or equity financing from the sale of common stock, preferred stock, and/or convertible debentures. Obtaining such working capital is not assured. The Company is currently in a production ramp up mode and placing greater emphasis on manufacturing capability.

The Marathon Credit Facility includes financial covenants that require our compliance beginning in the fourth quarter of 2019. We expect to be able to satisfy the covenant requirements either through results of operations or the available Equity Cure in the Credit Agreement.

In the opinion of Management, the Unaudited Condensed Consolidated Financial Statements include all adjustments that are necessary for the fair presentation of Workhorse’s financial conditions, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. Intercompany balances and transactions are eliminated in consolidation. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto of Workhorse contained in its Annual Report on Form 10-K for the year ended December 31, 2018.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

Certain reclassifications were made to the prior year financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operation or stockholders’ equity (deficit).

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

9. EARNINGS PER SHARE

Basic loss per share is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. For all periods presented, due to the Company’s net losses, all of the Company’s common stock equivalents were excluded from the calculation of diluted loss per share because they were anti-dilutive.

XML

Duke Financing Obligation

6 Months Ended

Jun. 30, 2019

Duke Financing Obligation [Abstract]

DUKE FINANCING OBLIGATION

DUKE FINANCING OBLIGATIONOn November 28, 2018, the Company entered into a Sales Agreement with Duke Energy One, Inc (“Duke”) pursuant to which the Company sold Duke 615,000 battery cells (the “615,000 Cells”) in consideration of $1,340,700. The

Company will continue to use the cells in the near term for the delivery of trucks to UPS and DHL. Until October 15, 2019, the Company has the right and option to require Duke to sell the 615,000 Cells back to the Company and Duke has the right and option to require the Company to purchase the 615,000 Cells at price equal to the price the 615,000 Cells were sold.

On November 28, 2018, in consideration for consenting to the Company selling the 615,000 Cells to Duke, which served as collateral for Arosa for their Loan Agreement, the Company entered into a Limited Consent, Waiver and Release pursuant to which the Company issued Arosa 2,000,000 shares of common stock and restruck the exercise price of warrants previously issued to $1.25 per share.

The Duke transactions was accounted for as a financing obligation and as such, the Company has recorded a $1,340,700 liability related to the transaction.

XML

Duke Financing Obligation (Details)	11 Months Ended
	Nov. 28, 2018 USD ($) $ / shares shares
Sales Agreement [Member]
Obligation with Joint and Several Liability Arrangement [Line Items]
Sales of battery cells units	$ 615,000
Sales consideration	$ 1,340,700
Sales description	Until October 15, 2019, the Company has the right and option to require Duke to sell the 615,000 Cells back to the Company and Duke has the right and option to require the Company to purchase the 615,000 Cells at price equal to the price the 615,000 Cells were sold.
Arosa [Member]
Obligation with Joint and Several Liability Arrangement [Line Items]
Stock warrants exercised | shares	2,000,000
Warrant exercise price (in usd per share) | $ / shares	$ 1.25
Duke financing obligation	$ 1,340,700

XML

Share Holders Equity (Deficit) (Details Textual) - USD ($)				6 Months Ended
	May 01, 2019	Feb. 11, 2019	Jun. 04, 2018	Jun. 30, 2019	Jun. 30, 2018
Share Holders Equity (Deficit) (Textual)
Deemed dividend			$ 765,179
Aggregate shares common stock			1,968,736
Subscription Agreements [Member]
Share Holders Equity (Deficit) (Textual)
Shares of common stock public offering	3,957,432
Public offering price per share	$ 0.74
Purchase of additional common stock, shares	116,496
Common stock purchase price		$ 1,465,056
Common stock purchase price, Shares		1,613,683
Net of proceeds from Issuance Initial Public Offering	$ 2,900,000
Underwriting Commitments, description				the Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of this offering at a per share purchase was $0.9501, which was above the closing price the date prior to close. They did not receive the Down Round protection.
Deemed dividend	$ 86,207
Minimum [Member]
Share Holders Equity (Deficit) (Textual)
Strike price of warrants					$ 2.62
Maximum [Member]
Share Holders Equity (Deficit) (Textual)
Strike price of warrants					$ 3.80

XML

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 23,519,496	$ 1,512,750
Lease receivable	42,244	48,271
Inventory	2,197,683	2,533,616
Prepaid expenses and deposits	1,720,319	2,274,595
Current assets, Total	27,479,742	6,369,232
Noncurrent assets:
Property, plant and equipment, net of accumulated depreciation of $2,601,263 and $2,407,477 at June 30, 2019 and December 31, 2018	8,009,037	5,237,451
Lease receivable	179,982	198,090
Assets, Total	35,668,761	11,804,773
Current liabilities:
Accounts payable	2,010,333	4,340,463
Accrued liabilities	4,047,550	3,946,386
Warranty liability	6,573,560	7,058,769
Warrant liability	15,876,415	1,822,819
Customer deposits	359,000	406,000
Duke financing obligation	1,340,700	1,340,700
Revolving loan	5,854,140	0
Total current liabilities	36,061,698	18,915,137
Long-term debt	8,572,182	8,312,079
Mandatory redeemable series B preferred stock	18,409,510	0
Commitments and Contingencies
Stockholders’ equity (deficit):
Series A preferred stock, par value of $.001 per share 75,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2019 and December 31, 2018	0	0
Common stock, par value of $.001 per share 250,000,000 shares authorized, 66,081,812 shares issued and outstanding at June 30, 2019 and 58,270,934 shares issued and outstanding at December 31, 2018	66,082	58,271
Additional paid-in capital	140,527,364	126,076,782
Accumulated deficit	(167,968,075)	(141,557,496)
Stockholders' equity (deficit), Total	(27,374,629)	(15,422,443)
Liabilities and Stockholders' Equity (Deficit), Total	$ 35,668,761	$ 11,804,773

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net loss	$ (26,324,372)	$ (13,327,103)
Adjustments to reconcile net loss to cash used by operations:
Depreciation	193,786	152,525
Amortization of Marathon loan issuance costs	260,103	0
Amortization of discount on Series B preferred stock	119,471	0
Amortized discount and debt issuance costs on Senior Secured Notes	0	987,500
Stock-based compensation	876,918	548,263
Inventory obsolescence reserve	22,221	0
Change in fair value of warrants	14,910,668	0
Effects of changes in operating assets and liabilities:
Accounts receivable and lease receivable	24,135	842,798
Inventory	313,712	(342,727)
Prepaid expenses and deposits	554,276	765,043
Accounts payable and accrued liabilities	(2,228,966)	1,980,433
Warranty	(485,209)	0
Notes payable, related parties	0	550,000
Customer deposits	(47,000)	265,595
Net cash used by operating activities	(11,810,257)	(7,577,673)
Cash flows from investing activities:
Capital expenditures	(2,965,372)	0
Net cash used by investing activities	(2,965,372)	0
Cash flows from financing activities:
Payments on long-term debt	0	(16,770)
Proceeds from revolving loans	5,854,140	0
Proceeds from issuance of series B preferred stock	25,000,000	0
Issuance of common stock	5,928,235	4,021,341
Exercise of warrants and options	0	90,066
Net cash provided by financing activities	36,782,375	4,094,637
Change in cash and cash equivalents	22,006,746	(3,483,036)
Cash and cash equivalents, beginning of the period	1,512,750	4,069,477
Cash and cash equivalents, end of the period	$ 23,519,496	$ 586,441

XML

Income Taxes

6 Months Ended

Jun. 30, 2019

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

8. INCOME TAXES

As the Company has not generated taxable income since inception, the cumulative deferred tax assets remain fully reserved, and no provision or liability for federal or state income taxes has been included in the financial statements.

XML

Long-Term Debt

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Long-term Debt [Text Block]

LONG-TERM DEBT (as restated)

Long-term debt consists of the following:

	June 30, 2019		December 31, 2018
Marathon Tranche One Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	$	10,000,000	$	10,000,000
Marathon Tranche Two Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	5,854,140		—
Marathon Credit Agreement unamortized discount and issuance costs	(1,427,818)		(1,687,921)
Net Marathon Credit Agreement	14,426,322		8,312,079
Less current portion	5,854,140		—
Long-term debt	$	8,572,182	$	8,312,079

On December 31, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”), with Marathon Asset Management, LP, on behalf of certain entities it manages, as lenders (collectively, the “Lenders”). The Credit Agreement provided the Company with a $10 million tranche of term loans (the “Tranche One Loan”) which may not be re-borrowed following repayment and (ii) a $25 million tranche of revolving loans which may be re-borrowed following repayment (the “Tranche Two Loans” together with the Tranche One Loan, the “Loans”).

The Trance Two Loan has been classified as current debt, because the agreement includes a lock box and cash sweep feature, which requires current presentation of the debt.

Second Amendment to Credit Agreement

On April 1, 2019, the Company entered into the Second Amendment to the Credit Agreement (the “Marathon Second Amendment”) with the Lenders. The Marathon Second Amendment delayed the application of certain financial covenants including:

(i)the minimum liquidity, providing that at least $4 million must be maintained at all times on or after April 30, 2019 rather than beginning on March 31, 2019;

(ii)the maximum total leverage ratio (ratio of total debt borrowed by the Company and its subsidiaries to EBITDA), providing that the maximum total leverage ratio shall not exceed 4.50:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which total leverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement; and

(iii)the maximum debt service coverage ratio (ratio of EBITDA (for the four consecutive fiscal quarters most recently ended, subject to certain adjustments set forth in the Credit Agreement) to interest expense and payments for operating leases), providing that the maximum debt service coverage ratio shall not exceed 1.25:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which debt service coverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement.

Third Amendment to Credit Agreement

On April 30, 2019, the Company entered into the Third Amendment to Credit Agreement (the “Marathon Third Amendment”). The Marathon Third Amendment amended the minimum liquidity covenant, providing that at least $4 million must be maintained at all times at or after May 31, 2019 rather than at all times on or after April 30, 2019. Unless the Company fails to maintain minimum liquidity as of the last day of any calendar month, the Company may cure a failure to maintain minimum liquidity by increasing liquidity to $4.0 million within five business days of the occurrence.

Purchase Warrants

In conjunction with entering into the Credit Agreement, the Company issued each Lender a Common Stock Purchase Warrant to purchase, in the aggregate, 8,053,390 shares of common stock at an exercise price of $1.25 per share exercisable in cash only for a period of three years and then for cash or cashless thereafter (collectively, the “Initial Warrants”). Until the later of the repayment of all obligations owed to the Lenders or two years from the closing date, the Company will be required to issue additional Common Stock Purchase Warrants (the “Additional Warrants”) to the Lenders equal to 10%, in the aggregate, of any additional equity issuances, subject to certain exceptions, on substantially the same terms and conditions of the Initial Warrants, except that (i) the applicable expiration date thereof shall be five years from the issuance date of the applicable warrant, (ii) the initial exercise price shall be a price equal to the price per share of common stock used in the relevant issuance multiplied by 110%, and (iii) the holder shall be entitled to exercise the warrant on a cashless exercise at any time the warrant is exercisable.

On April 16, 2019, the Company entered into an Amendment No. 1 to Common Stock Purchase Warrants with Marathon Asset Management LP, on behalf of certain entities it manages, as warrant holders (collectively, the “Holders”) (collectively, the “Marathon Warrant Amendment”), amending certain terms of the existing warrants issued by the Company in favor of each Holder. Pursuant to the Marathon Warrant Amendment, unless the Company has obtained the approval of its shareholders the number of shares to be issued under warrants held by the Holders shall not exceed 19.99% of the issued and outstanding common stock of the Company as of December 31, 2018. The Marathon Warrant Amendment also provide that the failure to obtain shareholder approval of an increase in the number of authorized shares of common stock of the Company, sufficient to enable the Company to issue common stock upon exercise of the warrants held by each Holder, will constitute an event of default under the existing Credit Agreement.

The Initial Warrants are required to be marked to market at each balance sheet date with a corresponding charge to interest expense. As of June 30, 2019 and December 31, 2018, the warrant liability was $15,876,415 and $965,747, respectively.

The Company has outstanding previously issued warrants to Arosa pursuant to agreements for debt issued in 2018. The Arosa debt was subsequently paid off on December 31, 2018, with the proceeds from the Credit Agreement. Through and including December 31, 2018, the warrants held by Arosa were required to be marked-to-market as the warrants were classified as liabilities. On January 1, 2019, the warrants no longer included dilution protection and therefore no longer met the criteria for liability classification and were reclassified to equity. As a result of the reclassification event, the $857,072 warrant liability for the Arosa warrants was reclassified as an increase to additional paid-in capital in 2019.

XML

Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

Subsequent Events [Text Block]

12. SUBSEQUENT EVENTS

The Company evaluates events and transactions occurring subsequent to the date of the condensed consolidated financial statements for matters requiring recognition or disclosure in the condensed consolidated financial statements. The accompanying condensed consolidated financial statements consider events through the date on which the condensed consolidated financial statements were available to be issued.

XML

Mandatory Redeemable Series B Preferred Stock (Details) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 05, 2019
Dividends description	The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% per annum on the Stated Value of the Preferred Stock. Accrued dividends will be payable quarterly in shares of common stock of the Company based on a fixed share price of $1.62. The Warrants have an exercise price of $1.62 per share, which was in excess of the closing price of $1.60 on May 30, 2019, and are immediately exercisable and will expire seven years from the date of issuance.
Stock issued exercise of warrants percentage	19.90%
Value of warrants issued with preferred stock	$ 6,700,000
Mandatory Redeemable Series B Preferred Stock [Member]
Warrant exercise price (in usd per share)		$ 7.41
Preferred Stock stated value		$ 20.00
Total proceeds received on the preferred stock		$ 25,000,000.0
Investors purchased		1,250,000

XML

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 0	$ 0
Property, plant and equipment, net of accumulated depreciation	$ 2,601,263	$ 2,407,477
Preferred stock par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	75,000,000	75,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value per share (in usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	250,000,000	250,000,000
Common stock, shares issued (in shares)	66,081,812	58,270,934
common stock, shares outstanding (in shares)	66,081,812	58,270,934

XML

Summary of Significant Accounting Principles

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]

SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES

The following accounting principles and practices are set forth to facilitate the understanding of data presented in the condensed consolidated financial statements:

Nature of operations and principles of consolidation

Workhorse Group Inc. (“Workhorse”, the “Company”, “we”, “us” or “our”) is a technology company focused on providing sustainable and cost-effective solutions to the commercial transportation sector. As an American manufacturer, we design and build high performance battery-electric vehicles and aircraft that make movement of people and goods more efficient and less harmful to the environment. As part of our solution, we also develop cloud-based, real-time telematics performance monitoring systems that enable fleet operators to optimize energy and route efficiency. Although we operate as a single unit through our subsidiaries, we approach our development through two divisions, Automotive and Aviation. We are currently focused on our core competency of bringing the N-GEN electric cargo van to market and fulfilling our existing backlog of orders. We are also exploring other opportunities in monetizing our intellectual property which could include a sale, license or other arrangement of assets that are outside of our core focus.

The Company’s wholly owned subsidiaries include Workhorse Technologies Inc., Workhorse Motor Works Inc., Workhorse Properties Inc. and Surefly, Inc

On May 3, 2019, the Company filed an amendment to its Articles of Incorporation to increase its authorized shares of common stock from 100,000,000 to 250,000,000.

Restatement of Previously Issued Consolidated Financial Statements

Subsequent to the filing of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019, filed with the SEC on August 9, 2019, management identified accounting adjustments related to an overstatement of the estimated warrant liability and interest expense. Certain warrants issued to lenders in 2018, were previously classified as liability financial instruments and marked-to-market at each reporting date with a corresponding adjustment to interest expense. On January 1, 2019, due to the payoff of debt to the lenders that the warrants were originally issued to, the warrants no longer met the criteria to be classified as liabilities and should have been reclassified to equity with no future mark-to-market adjustments. The adjustment resulted from the Company not recognizing that a reclassification event had occurred resulting in a change in the classification of certain of the Company’s outstanding warrants.

In addition, the Company determined that the classification of certain warrants issued in 2019 to lenders were misclassified as liability financial instruments, while they should have been classified as equity instruments and not marked-to-market.

Although the reclassification event occurred on January 1, 2019, and the missclassification of the 2019 warrants occurred in early 2019, management has determined that the $300,000 impact to the net loss for the three months ended March 31, 2019 is not material and therefore is not restating that period. The impact of the misstatement for the three months ended March 31, 2019, has been included in the adjustment for the three and six months ended June 30, 2019.

The following tables present the effect of the correction discussed above on selected line items of our previously reported consolidated balance sheet, consolidated statement of operations and statement of cash flows as of and for the three and six months ended June 30, 2019.

Condensed Consolidated Balance Sheet
	June 30, 2019
	As originally reported		Adjustments		As restated
Warrant liability	$	33,529,599	$	(17,653,184)	$	15,876,415
Additional paid-in capital	139,670,292		857,072		140,527,364
Accumulated deficit	(184,764,188)		16,796,113		(167,968,075)
Total shareholders' deficit	(45,027,814)		17,653,185		(27,374,629)

Condensed Consolidated Statement of Operations
	Three Months Ended June 30, 2019						Six Months Ended June 30, 2019
	As originally reported		Adjustments		As restated		As originally reported		Adjustments		As restated
Interest expense, net	$	32,718,876	$	(16,796,113)	$	15,922,763	$	34,496,459	$	(16,796,113)	$	17,700,346
Net loss	(36,856,313)		16,796,113		(20,060,200)		(43,120,485)		16,796,113		(26,324,372)
Net loss attributable to common stockholders	(36,942,520)		16,796,113		(20,146,407)		(43,206,692)		16,796,113		(26,410,579)
Net loss attributable to common stockholders per share - basic and diluted	$	(0.61)	$	0.28	$	(0.33)	$	(0.71)	$	0.28	$	(0.44)

Condensed Consolidated Statement of Cash Flows
	Six Months Ended June 30, 2019
	As originally reported	Adjustments	As restated
Net loss	(43,120,485)	16,796,113	(26,324,372)
Change in fair value of warrants	31,706,780	(16,796,112)	14,910,668

Basis of presentation

The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has limited revenues and a history of negative working capital and stockholders’ deficits. Our existing capital resources are expected to be sufficient to fund our operations through the end of 2019. Unless and until we are able to generate a sufficient amount of revenue, reduce our costs and/or enter a strategic relationship, we expect to finance future cash needs through public and/or private offerings of equity securities and/or debt financings. If we are not able to obtain additional financing and/or substantially increase revenue from sales, we will be unable to continue as a going concern. These conditions raise substantial doubt about the ability of the Company to continue as a going concern.

In view of these matters, continuation as a going concern is dependent upon the continued operations of the Company, which, in turn, is dependent upon the Company’s ability to meet its financial requirements, raise additional capital,

meet its future bank covenant requirements, and successfully carry out its future operations. The financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary, should the Company not continue as a going concern.

The Company has continued to raise capital. Management believes the proceeds from these offerings, future offerings, and the Company’s anticipated revenue, provides an opportunity to continue as a going concern.  If additional funding is required, the Company plans to obtain working capital from either debt or equity financing from the sale of common stock, preferred stock, and/or convertible debentures. Obtaining such working capital is not assured. The Company is currently in a production ramp up mode and placing greater emphasis on manufacturing capability.

The Marathon Credit Facility includes financial covenants that require our compliance beginning in the fourth quarter of 2019. We expect to be able to satisfy the covenant requirements either through results of operations or the available Equity Cure in the Credit Agreement.

In the opinion of Management, the Unaudited Condensed Consolidated Financial Statements include all adjustments that are necessary for the fair presentation of Workhorse’s financial conditions, results of operations and cash flows for the interim periods presented. Such adjustments are of a normal, recurring nature. Intercompany balances and transactions are eliminated in consolidation. The results of operations and cash flows for the interim periods presented may not necessarily be indicative of full-year results. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto of Workhorse contained in its Annual Report on Form 10-K for the year ended December 31, 2018.

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.

Certain reclassifications were made to the prior year financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operation or stockholders’ equity (deficit).

XML

Summary of Significant Accounting Principles (Details) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	May 03, 2019	Dec. 31, 2018
Number of authorized shares of common stock	250,000,000			250,000,000			250,000,000
Net loss	$ (20,060,200)		$ (6,909,297)	$ (26,324,372)	$ (13,327,103)
Immaterial error
Net loss		$ 300,000
Minimum [Member]
Number of authorized shares of common stock						100,000,000
Maximum [Member]
Number of authorized shares of common stock						250,000,000

XML

Revenue (Tables)

6 Months Ended

Jun. 30, 2019

Revenue Recognition and Deferred Revenue [Abstract]

Schedule of disaggregation of revenue

	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Automotive	—	118,398	240,000	523,252
Aviation	—	—	—	—
Other	5,508	52,286	129,690	207,661
Total revenues	5,508	170,684	369,690	730,913

XML

Long-Term Debt (Details Textual) - USD ($)		1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Apr. 02, 2019	Apr. 30, 2019	Jun. 30, 2019	Jun. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Class of Warrant Holder Percentage					19.99%
Warrant liability			$ 15,876,415	$ 15,876,415	$ 965,747
Effect of reclassification of warrants			$ 857,072	$ 857,072
Credit Agreement [Member]
Debt Instrument [Line Items]
Credit agreement, description	the minimum liquidity, providing that at least $4 million must be maintained at all times on or after April 30, 2019 rather than beginning on March 31, 2019;(ii)the maximum total leverage ratio (ratio of total debt borrowed by the Company and its subsidiaries to EBITDA), providing that the maximum total leverage ratio shall not exceed 4.50:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which total leverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement; and(iii)the maximum debt service coverage ratio (ratio of EBITDA (for the four consecutive fiscal quarters most recently ended, subject to certain adjustments set forth in the Credit Agreement) to interest expense and payments for operating leases), providing that the maximum debt service coverage ratio shall not exceed 1.25:1.00 on the last day of the quarter ending December 31, 2019, rather than beginning with the quarter ending September 30, 2019, which debt service coverage ratio is adjusted for subsequent quarters as set forth in the Credit Agreement.				On December 31, 2018, the Company entered into a Credit Agreement (the “Credit Agreement”), with Marathon Asset Management, LP, on behalf of certain entities it manages, as lenders (collectively, the “Lenders”). The Credit Agreement provided the Company with a $10 million tranche of term loans (the “Tranche One Loan”) which may not be re-borrowed following repayment and (ii) a $25 million tranche of revolving loans which may be re-borrowed following repayment (the “Tranche Two Loans” together with the Tranche One Loan, the “Loans”).
Amendment to credit agreement, description		the Company entered into the Third Amendment to Credit Agreement (the “Marathon Third Amendment”). The Marathon Third Amendment amended the minimum liquidity covenant, providing that at least $4 million must be maintained at all times at or after May 31, 2019 rather than at all times on or after April 30, 2019. Unless the Company fails to maintain minimum liquidity as of the last day of any calendar month, the Company may cure a failure to maintain minimum liquidity by increasing liquidity to $4.0 million within five business days of the occurrence.
Warrants to purchase of common stock shares				8,053,390
Warrant exercise price (in usd per share)			$ 1.25	$ 1.25
Warrants to purchase common stock, description				the Company will be required to issue additional Common Stock Purchase Warrants (the “Additional Warrants”) to the Lenders equal to 10%, in the aggregate, of any additional equity issuances, subject to certain exceptions, on substantially the same terms and conditions of the Initial Warrants, except that (i) the applicable expiration date thereof shall be five years from the issuance date of the applicable warrant, (ii) the initial exercise price shall be a price equal to the price per share of common stock used in the relevant issuance multiplied by 110%, and (iii) the holder shall be entitled to exercise the warrant on a cashless exercise at any time the warrant is exercisable.

XML

Share Holders Equity (Deficit) (Details) - Warrants [Member]	6 Months Ended
	Jun. 30, 2019 $ / shares shares
Number of Warrants, Beginning Balance	17,818,844
Number of Warrants, Granted, Series B Preferred Stock	9,262,500
Number of Warrants, Granted, Marathon debt	1,840,275
Number of Warrants, Exercised	0
Number of Warrants, Ending Balance	28,921,619
Weighted Average Exercise Price per Warrant, Beginning Balance | $ / shares	$ 1.84
Weighted Average Exercise Price per Warrant, Granted, Series B Preferred Stock | $ / shares	1.62
Weighted Average Exercise Price per Warrant, Granted, Marathon debt | $ / shares	1.40
Weighted Average Exercise Price per Warrant, Ending Balance | $ / shares	$ 2.58
Weighted Average Remaining Exercise Term in Months, Beginning Balance	52 months
Weighted Average Remaining Exercise Term in Months, Granted, Series B Preferred Stock	48 months
Weighted Average Remaining Exercise Term in Months, Granted, Marathon debt	60 months
Weighted Average Remaining Exercise Term in Months, Ending Balance	69 months

XML

Recent Accounting Developments

6 Months Ended

Jun. 30, 2019

Accounting Changes and Error Corrections [Abstract]

Accounting Changes and Error Corrections [Text Block]

10. RECENT ACCOUNTING DEVELOPMENTS

Accounting Guidance Adopted in 2019

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which requires a lessee to recognize in the statement of financial position a liability to make lease payments (“the lease liability”) and a right-of-use asset representing its right to use the underlying asset for the lease term, initially measured at the present value of the lease payments. A lessee shall classify a lease as a finance lease or an operating lease.

Amortization of the right-of-use asset shall be on a straight-line basis, unless another basis is more representative of the pattern in which the lessee expects to consume the right-of-use asset’s future economic benefits. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The amendments in this update were applied using the current period adjustment method, as defined, and were effective on January 1, 2019. The adoption of this standard did not have a material impact on the condensed consolidated financial statements.

XML

Mandatory Redeemable Series B Preferred Stock

6 Months Ended

Jun. 30, 2019

Series B Preferred Stock [Abstract]

MANDATORY REDEEMABLE SERIES B PREFERRED STOCK

. MANDATORY REDEEMABLE SERIES B PREFERRED STOCK

Commencing May 31, 2019 through June 5, 2019 (“Closing Date”), the Company entered into Subscription Agreements with institutional investors pursuant to which the investors purchased 1,250,000 units consisting of one share of Series B Preferred Stock (the “Preferred Stock”), with a stated value of $20.00 per share (the “Stated Value”) and a common stock purchase warrant to purchase 7.41 shares of the common stock (the “Warrants”) for an aggregate of purchase price of $25.0 million.

The Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights upon liquidation, winding-up or dissolution. The Preferred Stock is entitled to annual dividends at a rate equal to 8.0% per annum on the Stated Value of the Preferred Stock. Accrued dividends will be payable quarterly in shares of common stock of the Company based on a fixed share price of $1.62. The Warrants have an exercise price of $1.62 per share, which was in excess of the closing price of $1.60 on May 30, 2019, and are immediately exercisable and will expire seven years from the date of issuance.

The Preferred Stock is not convertible and does not hold voting rights.

On the fourth anniversary of the Closing Date, the Company is required to redeem all the outstanding shares of the Preferred Stock at the Stated Value, plus accrued and unpaid dividends. At any time prior to such date, the Company subject to the repayment and retirement of the Credit Agreement, may redeem any outstanding shares of Preferred Stock at the Stated Value, plus accrued and unpaid dividends (“Optional Redemption”). Notwithstanding the foregoing, the Company may elect an Optional Redemption prior to the fourth anniversary of the Closing Date so long as it obtains from the lenders to the Credit Agreement their prior written consent to such Optional Redemption.

The aggregate number of shares of common stock issued in payment of dividends on the Preferred Stock when added to the number of shares of common stock issued upon exercise of any warrants shall not exceed 19.9% of either (a) the total number of shares of common stock outstanding on the date hereof or (b) the total voting power of the Company’s securities outstanding on the date hereof that are entitled to vote on a matter being voted on by holders of the common stock, unless and until the Company obtains stockholder approval permitting such issuances.

As the Preferred Stock is mandatorily redeemable, it is presented as a liability on the condensed consolidated balance sheet. All dividends payable on the Preferred Stock are classified as interest expense.

The Preferred Stock and Warrants have been determined to be freestanding financial instruments and have been accounted for separately. The Warrants are considered equity instruments and are not required to be recorded as a liability and marked-to-market at each reporting period. On the date of issuance, the value of the Warrants was determined to be $6.7 million, which was determined using the Black-Scholes valuation model. The fair value of the warrants was recorded as an increase to Additional Paid-In Capital and a discount of the Preferred Stock. The discount will be amortized to interest expense through May 2023.

XML

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Jul. 31, 2019
Document and Entity Information [Abstract]
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	000-53704
Entity Registrant Name	WORKHORSE GROUP INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	26-1394771
Entity Address, Address Line One	100 Commerce Drive
Entity Address, City or Town	Loveland
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45140
City Area Code	844
Local Phone Number	937-9547
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	WKHS
Entity Common Stock, Shares Outstanding		66,186,447
Entity Central Index Key	0001425287
Amendment Flag	true
Amendment Description	Update for to previously filed information for warrants
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2

XML

Condensed Consolidated Statements of Stockholders Equity (Deficit) (Unaudited) - USD ($)	Total	Series A Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2017	$ 3,511,564	$ 0	$ 41,529	$ 107,760,036	$ (104,290,001)
Balance, Shares at Dec. 31, 2017			41,529,181
Issuance of common stock	4,021,341	0	$ 1,460	4,019,881
Issuance of common stock, shares			3,429,395
Stock options and warrants exercised	90,066	0	$ 45	90,021
Stock options and warrants exercised, shares			44,643
Warrant exchange	0	0	$ 1,969	(1,969)
Deemed dividend, Sept 17 warrants	0	0		765,179	(765,179)
Share based compensation	548,263	0		548,263
Net loss	(13,327,103)	0			(13,327,103)
Balance at Jun. 30, 2018	(5,155,869)	0	$ 45,003	113,181,411	(118,382,283)
Balance, Shares at Jun. 30, 2018			45,003,219
Balance at Mar. 31, 2018	(1,559,334)	0	$ 41,966	109,106,507	(110,707,807)
Balance, Shares at Mar. 31, 2018			41,966,550
Issuance of common stock	2,833,926	0	$ 1,065	2,832,861
Issuance of common stock, shares			3,034,169
Stock options and warrants exercised	2,751	0	$ 3	2,748
Stock options and warrants exercised, shares			2,500
Warrant exchange	0	0	$ 1,969	(1,969)
Deemed dividend, Sept 17 warrants	0	0		765,179	(765,179)
Share based compensation	476,085	0		476,085
Net loss	(6,909,297)	0			(6,909,297)
Balance at Jun. 30, 2018	(5,155,869)	0	$ 45,003	113,181,411	(118,382,283)
Balance, Shares at Jun. 30, 2018			45,003,219
Balance at Dec. 31, 2018	(15,422,443)		$ 58,271	126,076,782	(141,557,496)
Balance, Shares at Dec. 31, 2018			58,270,934
Balance at Mar. 31, 2019	(17,995,810)	0	$ 61,497	129,764,361	(147,821,668)
Balance, Shares at Mar. 31, 2019			61,496,990
Balance at Dec. 31, 2018	(15,422,443)		$ 58,271	126,076,782	(141,557,496)
Balance, Shares at Dec. 31, 2018			58,270,934
Issuance of common stock	5,928,235	0	$ 7,184	5,921,051
Issuance of common stock, shares			7,183,488
Stock options and warrants exercised	0	0	$ 511	(511)
Stock options and warrants exercised, shares			510,894
Deemed dividend, Sept 17 warrants			$ 116	86,091	(86,207)
Deemed dividend, Sept 17 warrants, shares			116,496
Share based compensation	876,918	0		876,918
Effect of reclassification of warrants	857,072			857,072
Value of warrants issued with preferred stock	6,709,961	0		6,709,961
Net loss	(26,324,372)	0			(26,324,372)
Balance at Jun. 30, 2019	(27,374,629)	0	$ 66,082	140,527,364	(167,968,075)
Balance, Shares at Jun. 30, 2019			66,081,812
Balance at Mar. 31, 2019	(17,995,810)	0	$ 61,497	129,764,361	(147,821,668)
Balance, Shares at Mar. 31, 2019			61,496,990
Issuance of common stock	2,928,500	0	$ 3,958	2,924,542
Issuance of common stock, shares			3,957,432
Stock options and warrants exercised	0	0	$ 511	(511)
Stock options and warrants exercised, shares			510,894
Deemed dividend, Sept 17 warrants			$ 116	86,091	(86,207)
Deemed dividend, Sept 17 warrants, shares			116,496
Share based compensation	185,848	0	$ 0	185,848
Effect of reclassification of warrants	857,072			857,072
Value of warrants issued with preferred stock	6,709,961	0		6,709,961
Net loss	(20,060,200)	0			(20,060,200)
Balance at Jun. 30, 2019	$ (27,374,629)	$ 0	$ 66,082	$ 140,527,364	$ (167,968,075)
Balance, Shares at Jun. 30, 2019			66,081,812

XML

Revenue

6 Months Ended

Jun. 30, 2019

Revenue Recognition and Deferred Revenue [Abstract]

Deferred Revenue Disclosure [Text Block]

REVENUE

Revenue Recognition

Net sales include products and shipping and handling charges, net of estimates for customer allowances. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with the majority of revenue recognized at the point in time the customer obtains control of the products. We recognize revenue for shipping and handling charges at the time the products are delivered to or picked up by the customer. The majority of our contracts have a single performance obligation and are short term in nature.

Accounts Receivable

Credit is extended based upon an evaluation of the customer’s financial condition. Accounts receivable are stated at their estimated net realizable value. The allowance for doubtful accounts is based on an analysis of customer accounts and our historical experience with accounts receivable write-offs. 

The Company has elected the following practical expedient allowed under ASU 2014-09. Performance obligations are satisfied within one year from a given reporting date, consequently we omit disclosure of the transaction price apportioned to remaining performance obligations on open orders

Disaggregation of Revenue

Our revenues related to the following types of business were as follows for the periods ended June 30, 2019:

	Three Months Ended June 30,		Six Months Ended June 30,
	2019	2018	2019	2018
Automotive	—	118,398	240,000	523,252
Aviation	—	—	—	—
Other	5,508	52,286	129,690	207,661
Total revenues	5,508	170,684	369,690	730,913

XML

Inventory (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Inventory, Net [Abstract]
Raw materials	$ 4,285,830	$ 4,319,637
Work in process	422,176	702,079
Finished goods	0	0
Inventory, gross	4,708,006	5,021,716
Less: Inventory reserve	2,510,323	2,488,100
Inventory, total	$ 2,197,683	$ 2,533,616

XML

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Option, Activity [Table Text Block]

		Outstanding Stock Options
	Options Available for Grant	Number of Options Outstanding	Weighted Average Exercise Price per Option		Weighted Average Grant Date Fair Value  per Option		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2017	4,145,774	3,851,371	$	3.11	$	1.84	43
Granted	(340,000)	340,000	1.18		0.54		56
Exercised	—	(52,500)	1.24		0.68		—
Forfeited	—	—	—		—		—
Expired	—	(271,250)	3.22		1.58		—
Balance, December 31, 2018	3,805,774	3,867,621	4.05		$	1.84	64
Additional Shares Authorized under 2019 Plan	8,000,000	—
Granted	(2,400,000)	2,400,000	0.96		0.53		81
Exercised	—	(498,552)	0.13		1.92
Forfeited	1,375,069	(1,375,069)	4.75		1.95		27
Expired	—	—
Balance, June 30, 2019	10,780,843	4,394,000	$	2.60	$	1.32	94

XML

Summary of Significant Accounting Principles (Tables)

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

The following tables present the effect of the correction discussed above on selected line items of our previously reported consolidated balance sheet, consolidated statement of operations and statement of cash flows as of and for the three and six months ended June 30, 2019.

Condensed Consolidated Balance Sheet
	June 30, 2019
	As originally reported		Adjustments		As restated
Warrant liability	$	33,529,599	$	(17,653,184)	$	15,876,415
Additional paid-in capital	139,670,292		857,072		140,527,364
Accumulated deficit	(184,764,188)		16,796,113		(167,968,075)
Total shareholders' deficit	(45,027,814)		17,653,185		(27,374,629)

Condensed Consolidated Statement of Operations
	Three Months Ended June 30, 2019						Six Months Ended June 30, 2019
	As originally reported		Adjustments		As restated		As originally reported		Adjustments		As restated
Interest expense, net	$	32,718,876	$	(16,796,113)	$	15,922,763	$	34,496,459	$	(16,796,113)	$	17,700,346
Net loss	(36,856,313)		16,796,113		(20,060,200)		(43,120,485)		16,796,113		(26,324,372)
Net loss attributable to common stockholders	(36,942,520)		16,796,113		(20,146,407)		(43,206,692)		16,796,113		(26,410,579)
Net loss attributable to common stockholders per share - basic and diluted	$	(0.61)	$	0.28	$	(0.33)	$	(0.71)	$	0.28	$	(0.44)

Condensed Consolidated Statement of Cash Flows
	Six Months Ended June 30, 2019
	As originally reported	Adjustments	As restated
Net loss	(43,120,485)	16,796,113	(26,324,372)
Change in fair value of warrants	31,706,780	(16,796,112)	14,910,668

XML

Share Holders Equity (Deficit) (Tables)

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Schedule of warrant activity

	Number of Warrants	Weighted Average Exercise Price per Warrant		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2018	17,818,844	$	1.84	52
Granted, Series B Preferred Stock	9,262,500	1.62		48
Granted, Marathon debt	1,840,275	1.40		60
Exercised	—
Balance, June 30, 2019	28,921,619	$	2.58	69

XML

Inventory (Tables)

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

	2019		2018
Raw materials	$	4,285,830	$	4,319,637
Work in process	422,176		702,079
Finished goods	—		—
	4,708,006		5,021,716
Less: Inventory reserve	2,510,323		2,488,100
	$	2,197,683	$	2,533,616

XML

Revenue (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Total revenues	$ 5,508	$ 170,684	$ 369,690	$ 730,913
Automotive [Member]
Total revenues	0	118,398	240,000	523,252
Aviation [Member]
Total revenues	0	0	0	0
Other [Member]
Total revenues	$ 5,508	$ 52,286	$ 129,690	$ 207,661

XML

Long-Term Debt (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Less current portion	$ 5,854,140	$ 0
Long-term debt	8,572,182	8,312,079
Marathon Tranche Loan [Member]
Debt Instrument [Line Items]
Marathon Tranche One Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	10,000,000	10,000,000
Marathon Tranche Two Loan, due December 31, 2021, interest only quarterly payments, variable interest rate of 10.25% as of June 30, 2019	5,854,140	0
Marathon Credit Agreement unamortized discount and issuance costs	(1,427,818)	(1,687,921)
Net Marathon Credit Agreement	$ 14,426,322	$ 8,312,079

XML

Stock Based Compensation (Details) - Stock Options [Member] - Directors, officers, consultants and employees [Member] - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Options Available for Grant
Options Available for Grant, Outstanding, Beginning Balance	3,805,774	4,145,774
Options Available for Grant, Additional Shares Authorized under 2019 Plan	8,000,000
Options Available for Grant, Granted	(2,400,000)	(340,000)
Options Available for Grant, Exercised		0
Options Available for Grant, Forfeited	1,375,069	0
Options Available for Grant, Expired		0
Options Available for Grant, Outstanding, Ending Balance	10,780,843	3,805,774
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options Outstanding, Beginning Balance	3,867,621	3,851,371
Number of Options Outstanding, Granted	2,400,000	340,000
Number of Options Outstanding, Exercised	(498,552)	(52,500)
Number of Options Outstanding, Forfeited	(1,375,069)	0
Number of Options Outstanding, Expired		(271,250)
Number of Options Outstanding, Ending Balance	4,394,000	3,867,621
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted Average Exercise Price per Option, Outstanding, Beginning Balance	$ 4.05	$ 3.11
Weighted Average Exercise Price per Option, Granted	0.96	1.18
Weighted Average Exercise Price per Option, Exercised	0.13	1.24
Weighted Average Exercise Price per Option, Forfeited	4.75	0
Weighted Average Exercise Price per Option, Expired		3.22
Weighted Average Exercise Price per Option, Outstanding, Ending Balance	2.60	4.05
Weighted Average Grant Date Fair Value per Option
Weighted Average Grant Date Fair Value per Option, Outstanding, Beginning Balance	1.84	1.84
Weighted Average Grant Date Fair Value per Option, Granted	0.53	0.54
Weighted Average Grant Date Fair Value per Option, Exercised	1.92	0.68
Weighted Average Grant Date Fair Value per Option, Forfeited	1.95	0
Weighted Average Grant Date Fair Value per Option, Expired		1.58
Weighted Average Grant Date Fair Value per Option, Outstanding, Ending Balance	$ 1.32	$ 1.84
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Exercise Term in Months, Outstanding, Beginning Balance	64 months	43 months
Weighted Average Remaining Exercise Term in Months, Granted	81 months	56 months
Weighted Average Remaining Exercise Term in Months, Forfeited	27 months
Weighted Average Remaining Exercise Term in Months, Outstanding, Ending Balance	94 months	64 months

XML

Share Holders Equity (Deficit)

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

SHARE HOLDERS EQUITY (DEFICIT)

Stock Offerings

On June 4, 2018, the Company and holders of all outstanding Warrants to Purchase Common Stock of the Company issued on September 18, 2017 (collectively, the “Warrants”) entered into separate, privately-negotiated exchange agreements (the “Exchange Agreements”), pursuant to which the Company issued an aggregate of 1,968,736 shares of the Company’s common stock in exchange for the Warrants. In addition, the “Down Round” feature of the Warrants was triggered in the second quarter of 2018, causing the strike price to decrease from $3.80 per share to $2.62 per share. As a result, the Company recorded a deemed dividend of $765,179 which represents the fair value transferred to the Warrant holders from the Down Round being triggered. The deemed dividend was recorded as a reduction of Retained Earnings and increase in Additional Paid-in-Capital and reduced net income available to common shareholders by the same amount.

Commencing February 11, 2019, the Company entered into and closed Subscription Agreements with accredited investors (the “February 2019 Accredited Investors”) for the purchase of 1,613,683 shares of the Company’s common stock for a purchase price of $1,465,056. If, prior to the six month anniversary, the Company issues shares of its common stock for a purchase price per share less than the purchase price paid by the February 2019 Accredited Investors (a “Down Round”), the Company will issue additional shares of common stock (for no additional consideration) such that the effective purchase price per share is equal to the purchase price per share paid in the Down Round. The Down Round provisions were triggered by the May 1, 2019 sale of common stock and an additional 116,496 shares of common stock were issued to the February 2019 Accredited Investors. The issuance of the additional shares is accounted for as a $86,207 deemed dividend.

Benjamin Samuels and Gerald Budde, directors of the Company, acquired 841,928 and 26,310 shares of common stock, respectively, as part of this offering at a per share purchase was $0.9501, which was above the closing price the date prior to close. They did not receive the Down Round protection.

On May 1, 2019, the Company closed under a registered public offering the sale of $3,957,432 shares of Common Stock for a purchase price of $0.74 per share. The net proceeds to the Company were approximately $2.9 million, after deducting estimated expenses payable by the Company. The Company expects to use the net proceeds from this offering for working capital, general corporate purposes and repayment of debt and other obligations.

Warrants

In connection with the issuance of debt and preferred stock, the Company has issued warrants to purchase share of Common Stock.

The following table summarizes warrant activity for the period:

	Number of Warrants	Weighted Average Exercise Price per Warrant		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2018	17,818,844	$	1.84	52
Granted, Series B Preferred Stock	9,262,500	1.62		48
Granted, Marathon debt	1,840,275	1.40		60
Exercised	—
Balance, June 30, 2019	28,921,619	$	2.58	69

XML

Stock-Based Compensation

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement [Text Block]

7. 

STOCK-BASED COMPENSATION

Options to directors, officers, consultants and employees

The Company maintains, as adopted by the board of directors, the 2019 Stock Incentive Plan as well as previous years plans (the “Plans”) providing for the issuance of equity based awards to employees, officers, directors or consultants of the Company. Non-qualified stock options granted under the plans may only be granted with an exercise price equal to the fair market value of the Company’s common stock on the date of grant.  Awards under the plans may be either vested or unvested options.

In addition to the Plans, the Company has granted, on various dates, stock options to directors, officers, consultants and employees to purchase common stock of the Company. The terms, exercise prices and vesting of these awards vary.

The following table summarizes option activity for directors, officers, consultants and employees:

		Outstanding Stock Options
	Options Available for Grant	Number of Options Outstanding	Weighted Average Exercise Price per Option		Weighted Average Grant Date Fair Value  per Option		Weighted Average Remaining Exercise Term in Months
Balance, December 31, 2017	4,145,774	3,851,371	$	3.11	$	1.84	43
Granted	(340,000)	340,000	1.18		0.54		56
Exercised	—	(52,500)	1.24		0.68		—
Forfeited	—	—	—		—		—
Expired	—	(271,250)	3.22		1.58		—
Balance, December 31, 2018	3,805,774	3,867,621	4.05		$	1.84	64
Additional Shares Authorized under 2019 Plan	8,000,000	—
Granted	(2,400,000)	2,400,000	0.96		0.53		81
Exercised	—	(498,552)	0.13		1.92
Forfeited	1,375,069	(1,375,069)	4.75		1.95		27
Expired	—	—
Balance, June 30, 2019	10,780,843	4,394,000	$	2.60	$	1.32	94

XML

Inventory

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

INVENTORY

As of June 30, 2019, and December 31, 2018, our inventory consisted of the following:

	2019		2018
Raw materials	$	4,285,830	$	4,319,637
Work in process	422,176		702,079
Finished goods	—		—
	4,708,006		5,021,716
Less: Inventory reserve	2,510,323		2,488,100
	$	2,197,683	$	2,533,616

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Net sales	$ 5,508	$ 170,684	$ 369,690	$ 730,913
Cost of sales	930,164	1,655,905	2,327,770	3,370,275
Gross loss	(924,656)	(1,485,221)	(1,958,080)	(2,639,362)
Operating expenses
Selling, general and administrative	1,996,054	3,003,202	4,086,944	5,403,349
Research and development	1,216,727	1,894,712	2,579,002	4,232,343
Total operating expenses	3,212,781	4,897,914	6,665,946	9,635,692
Interest expense, net	15,922,763	526,162	17,700,346	1,052,049
Net loss	(20,060,200)	(6,909,297)	(26,324,372)	(13,327,103)
Deemed dividends	86,207	765,179	86,207	765,179
Net loss attributable to common stockholders	$ (20,146,407)	$ (7,674,476)	$ (26,410,579)	$ (14,092,282)
Basic and diluted earnings per share (in usd per share)	$ (0.33)	$ (0.18)	$ (0.44)	$ (0.33)
Weighted average number of common shares outstanding	60,530,168	42,406,471	60,530,168	42,406,471